<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:32:26Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2475692" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2475692</identifier><datestamp>2008-09-22</datestamp><setSpec>jbc</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
      <journal-id journal-id-type="publisher-id">jbc</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Biological Chemistry</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0021-9258</issn>
      <issn pub-type="epub">1083-351X</issn>
      <publisher>
        <publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2475692</article-id>
      <article-id pub-id-type="pmcid">PMC2475692</article-id>
      <article-id pub-id-type="pmc-uid">2475692</article-id>
      <article-id pub-id-type="pmid">18482979</article-id>
      <article-id pub-id-type="publisher-id">20733</article-id>
      <article-id pub-id-type="doi">10.1074/jbc.M802254200</article-id>
      <article-id pub-id-type="pmid">18482979</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Mechanisms of Signal Transduction</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Modulation of Voltage- and Ca<sup>2+</sup>-dependent Gating of
 Ca<sub>V</sub>1.3 L-type Calcium Channels by Alternative Splicing of a
 C-terminal Regulatory
 Domain<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>Anamika</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">â¡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gebhart</surname>
            <given-names>Mathias</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">â¡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fritsch</surname>
            <given-names>Reinhard</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">Â§</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sinnegger-Brauns</surname>
            <given-names>Martina J.</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">â¡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Poggiani</surname>
            <given-names>Chiara</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">â¡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoda</surname>
            <given-names>Jean-Charles</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">â¡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Engel</surname>
            <given-names>Jutta</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">Â¶</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Romanin</surname>
            <given-names>Christoph</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">Â§</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Striessnig</surname>
            <given-names>JÃ¶rg</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">â¡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koschak</surname>
            <given-names>Alexandra</given-names>
          </name>
          <xref ref-type="aff" rid="d31e122">â¡</xref>
          <xref ref-type="corresp" rid="cor1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="d31e122"><label>â¡</label>Institute of Pharmacy, Pharmacology, and
 Toxicology, and Center for Molecular Biosciences, University of Innsbruck,
 Peter-Mayr-Strasse 1/I, A-6020 Innsbruck, Austria,
 <label>Â§</label>Institute of Biophysics, University of Linz,
 Altenbergerstrasse 69, A-4040 Linz, Austria, and
 <label>Â¶</label>Institute of Physiology II and TÃ¼bingen
 Hearing Research Centre, University of TÃ¼bingen, D-72076 TÃ¼bingen,
 Germany</aff>
      <author-notes>
        <corresp id="cor1"><label>1</label>
 To whom correspondence should be addressed. Tel.: 43-512-507-5602; Fax:
 42-512-507-2931; E-mail:
 <email>alexandra.koschak@uibk.ac.at</email>.
 </corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>25</day>
        <month>7</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>25</day>
        <month>7</month>
        <year>2008</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on 
			/art/copyright. -->
      <volume>283</volume>
      <issue>30</issue>
      <fpage>20733</fpage>
      <lpage>20744</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>3</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>13</day>
          <month>5</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2008, The American Society for Biochemistry and
 Molecular Biology, Inc.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license license-type="open-access">
          <license-p>
            <italic>Author's Choice</italic>
          </license-p>
          <license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non-Commercial
 License</ext-link> applies to Author Choice Articles</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:href="zbc03008020733.pdf"/>
      <abstract>
        <p>Low voltage activation of Ca<sub>V</sub>1.3 L-type Ca<sup>2+</sup> channels
 controls excitability in sensory cells and central neurons as well as
 sinoatrial node pacemaking. Ca<sub>V</sub>1.3-mediated pacemaking determines
 neuronal vulnerability of dopaminergic striatal neurons affected in Parkinson
 disease. We have previously found that in Ca<sub>V</sub>1.4 L-type
 Ca<sup>2+</sup> channels, activation, voltage, and calcium-dependent
 inactivation are controlled by an intrinsic distal C-terminal modulator.
 Because alternative splicing in the Ca<sub>V</sub>1.3 Î±1 subunit C
 terminus gives rise to a long (Ca<sub>V</sub>1.3<sub>42</sub>) and a short
 form (Ca<sub>V</sub>1.3<sub>42A</sub>), we investigated if a C-terminal
 modulatory mechanism also controls Ca<sub>V</sub>1.3 gating. The biophysical
 properties of both splice variants were compared after heterologous expression
 together with Î²3 and Î±2Î´1 subunits in HEK-293 cells.
 Activation of calcium current through Ca<sub>V</sub>1.3<sub>42A</sub> channels
 was more pronounced at negative voltages, and inactivation was faster because
 of enhanced calcium-dependent inactivation. By investigating several
 Ca<sub>V</sub>1.3 channel truncations, we restricted the modulator activity to
 the last 116 amino acids of the C terminus. The resulting
 Ca<sub>V</sub>1.3<sub>ÎC116</sub> channels showed gating properties
 similar to Ca<sub>V</sub>1.3<sub>42A</sub> that were reverted by co-expression
 of the corresponding C-terminal peptide C<sub>116</sub>. Fluorescence
 resonance energy transfer experiments confirmed an intramolecular protein
 interaction in the C terminus of Ca<sub>V</sub>1.3 channels that also
 modulates calmodulin binding. These experiments revealed a novel mechanism of
 channel modulation enabling cells to tightly control Ca<sub>V</sub>1.3 channel
 activity by alternative splicing. The absence of the C-terminal modulator in
 short splice forms facilitates Ca<sub>V</sub>1.3 channel activation at lower
 voltages expected to favor Ca<sub>V</sub>1.3 activity at threshold voltages as
 required for modulation of neuronal firing behavior and sinoatrial node
 pacemaking.</p>
      </abstract>
    </article-meta>
    <notes>
      <fn-group>
        <fn>
          <p><italic>Author's Choice</italic>âFinal version full access.</p>
        </fn>
        <fn id="fn1">
          <label>*</label>
          <p>This work was supported by the <funding-source>Austrian Science
 Funds</funding-source> P17159 (to J. S.) and P18169 (to C. R.), the
 <funding-source>Tyrolean Science Fund</funding-source> UNI-0404/353 (to A. K.),
 <funding-source>European Community Grant Cavnet</funding-source>,
 MRTN-CT-2006-35367, and the <funding-source>University of
 Innsbruck</funding-source>. The costs of publication of this article were
 defrayed in part by the payment of page charges. This article must therefore
 be hereby marked â<italic>advertisement</italic>â in accordance with 18
 U.S.C. Section 1734 solely to indicate this fact.</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body>
    <p>Ca<sup>2+</sup> influx through voltage-gated L-type Ca<sup>2+</sup>
 channels (LTCCs)<xref ref-type="fn" rid="fn2">2</xref>
 regulates numerous physiological functions, including muscle contraction,
 hormone release, neuronal firing and plasticity, sensory function, and cardiac
 pacemaking (<xref ref-type="bibr" rid="ref1">1</xref>). Four
 pore-forming Î±1 subunit isoforms
 (Ca<sub>V</sub>1.1âCa<sub>V</sub>1.4) with different biophysical
 properties and expression profiles evolved to adjust LTCC Ca<sup>2+</sup>
 signals to cellular needs. Ca<sub>V</sub>1.3 channels play a unique role for
 hearing (sensory signaling in cochlear inner hair cells (IHC)) and sinoatrial
 node (SAN, diastolic depolarization) function
 (<xref ref-type="bibr" rid="ref2">2</xref>). Ca<sub>V</sub>1.3 channels
 appear ideally suited for these functions because the operating range of both
 IHCs and SAN cells is within a voltage range of about â60 and â40
 mV where these channels can conduct inward current because of their negative
 activation range (Refs.
 <xref ref-type="bibr" rid="ref3">3</xref>â<xref ref-type="bibr" rid="ref5">5</xref>
 and for review see Ref. <xref ref-type="bibr" rid="ref6">6</xref>). In
 neurons, Ca<sub>V</sub>1.3 channels also serve pacemaker function and shape
 neuronal firing (<xref ref-type="bibr" rid="ref7">7</xref>,
 <xref ref-type="bibr" rid="ref8">8</xref>). Ca<sup>2+</sup> influx
 through LTCCs is limited by a Ca<sup>2+</sup>-dependent feedback mechanism,
 the so-called calcium-dependent inactivation (CDI)
 (<xref ref-type="bibr" rid="ref9">9</xref>). CDI develops in response
 to local or global elevations of intracellular Ca<sup>2+</sup> sensed by
 channel-bound calmodulin (<xref ref-type="bibr" rid="ref10">10</xref>,
 <xref ref-type="bibr" rid="ref11">11</xref>). However, moderation of
 CDI is an important prerequisite in some cells, such as in IHCs
 (Ca<sub>V</sub>1.3; 12â14) and in retinal photoreceptors
 (Ca<sub>V</sub>1.4), where slow inactivation of <italic>I</italic><sub>Ca</sub> is
 required for sensory signaling. In Ca<sub>V</sub>1.4 channels, CDI is
 completely prevented by an intrinsic gating modulator located in the
 Ca<sub>V</sub>1.4Î±1 C terminus, and CDI is restored in C-terminal
 truncation mutants (<xref ref-type="bibr" rid="ref15">15</xref>,
 <xref ref-type="bibr" rid="ref16">16</xref>). This C-terminal gating
 modulator (CTM) not only prevents CDI but also shifts the activation voltage
 range to more positive potentials
 (<xref ref-type="bibr" rid="ref15">15</xref>). Gating modulation seems
 not to be limited to Ca<sub>V</sub>1.4 because co-expression of C-terminal
 fragments of Ca<sub>V</sub>1.2 channels also shifts their activation range to
 more positive voltages and inhibits pore opening
 (<xref ref-type="bibr" rid="ref17">17</xref>). Because C termini of
 Ca<sub>V</sub>1.2 (and also Ca<sub>V</sub>1.1) Î±1 subunits are
 proteolytically cleaved
 (<xref ref-type="bibr" rid="ref18">18</xref>â<xref ref-type="bibr" rid="ref20">20</xref>)
 but remain noncovalently bound to proximal C-terminal domains, they may serve
 as autoinhibitory modules (<xref ref-type="bibr" rid="ref17">17</xref>,
 <xref ref-type="bibr" rid="ref21">21</xref>).</p>
    <p>We hypothesized that Ca<sub>V</sub>1.3 function may also be fine-tuned by a
 CTM domain similar to Ca<sub>V</sub>1.1, Ca<sub>V</sub>1.2, and
 Ca<sub>V</sub>1.4. Unlike for other LTCC Î±1 subunits, alternative
 splicing generates Ca<sub>V</sub>1.3 Î±1 subunits with long (usage of
 exon 42, Ca<sub>V</sub>1.3<sub>42</sub>) or short (usage of exon 42A,
 Ca<sub>V</sub>1.3<sub>42A</sub>) C termini. A CTM would therefore confer
 different biophysical properties on Ca<sub>V</sub>1.3 only if present as in
 certain (<italic>i.e.</italic> long) variants.</p>
    <p>Here we provide unequivocal evidence that an intramolecular protein-protein
 interaction gives rise to substantial gating differences between
 Ca<sub>V</sub>1.3<sub>42</sub> and Ca<sub>V</sub>1.3<sub>42A</sub>. Our
 finding that the long and the short splice variants are expressed in several
 mouse and human tissues suggests that both contribute to fine-tuning of
 physiological Ca<sub>V</sub>1.3 channel function.</p>
    <sec sec-type="methods">
      <title>EXPERIMENTAL PROCEDURES</title>
      <sec>
        <title>Cloning of cDNA Constructs</title>
        <p>To generate splice variant Ca<sub>V</sub>1.3<sub>42A</sub>, the
 alternatively spliced exon 42A was introduced into Ca<sub>V</sub>1.3 cDNA
 (Ca<sub>V</sub>1.3<sub>42</sub> = human Ca<sub>V</sub>1.3<sub>8A</sub> as in
 Ref. <xref ref-type="bibr" rid="ref4">4</xref>, GenBankâ¢
 accession number EU363339) by co-ligating an EcoRI-BamHI-cut PCR product
 containing exon 42A from a rat brain Î±1 subunit (GenBankâ¢
 accession number M57682) with HindIII-EcoRI-cut Ca<sub>V</sub>1.3 cDNA into
 HindIII-BamHI (4622â7100)-cut Ca<sub>V</sub>1.3-pBS vector. The rat exon
 42A amino acid sequence is identical to its human homologue. Human
 Ca<sub>V</sub>1.3 containing exon 42A was subsequently cloned into vector
 pGFP<sup>â</sup> (wild type) short form of the Ca<sub>V</sub>1.3 protein
 (<xref ref-type="bibr" rid="ref4">4</xref>). For analyzing the effects
 of exon 44, amino acid residues RTRYYETYI were introduced into an untagged
 construct containing the long Ca<sub>V</sub>1.3 C terminus after position 1787
 using standard PCR techniques. Ca<sub>V</sub>1.3<sub>ÎC473</sub>,
 Ca<sub>V</sub>1.3<sub>ÎC158</sub>,
 Ca<sub>V</sub>1.3<sub>ÎC116</sub>, and
 Ca<sub>V</sub>1.3<sub>ÎC76</sub> channels were constructed by
 introducing stop codons into untagged Ca<sub>V</sub>1.3<sub>42</sub> at
 respective amino acid positions 1665, 1980, 2022, and 2062 followed by
 artificial restriction sites as follows: BamHI* for
 Ca<sub>V</sub>1.3<sub>ÎC158</sub> and
 Ca<sub>V</sub>1.3<sub>ÎC76</sub>, HpaI* for
 Ca<sub>V</sub>1.3<sub>ÎC116</sub>, and XhoI* for
 Ca<sub>V</sub>1.3<sub>ÎC473</sub>. Peptides GFP-C<sub>158</sub>,
 GFP-C<sub>116</sub>, and GFP-C<sub>76</sub> were constructed by ligating
 HindIII*-SalI*-flanked PCR products corresponding to amino acids
 1980â2137, 2022â2137, and 2062â2137 of
 Ca<sub>V</sub>1.3<sub>42</sub> into the pGFP<sup>+</sup> plasmid resulting in
 the corresponding GFP-tagged Ca<sub>V</sub>1.3 C-terminal peptides
 (<xref ref-type="bibr" rid="ref22">22</xref>). For FRET analysis, all
 C-terminal Ca<sub>V</sub>1.3 fragments were cloned either into the mammalian
 expression vector <italic>pEYFP-C1</italic> for N-terminal EYFP labeling or vector
 <italic>pECFP-N1</italic> for C-terminal enhanced CFP labeling (Clontech).
 N-terminally EYFP-labeled constructs 5â²-HindIII* and 3â²-SalI*
 restriction sites flanking nucleotide sequences corresponding to the following
 Ca<sub>V</sub>1.3 amino acid positions were introduced and cloned into
 HindIII-SalI-cut vector <italic>pEYFP-C1</italic> as follows: peptide
 EF-preIQ-IQ-postIQ, amino acids 1453â2137; EF-preIQ-IQ, amino acids
 1453â1623; and EF-preIQ-IQ-PCRD, amino acids 1453â1664. To
 construct peptide EF-preIQ-IQ-PCRD<sup>RRQQ</sup>, arginines at positions 1640
 and 1641 were mutated to glutamines by splicing by overlapping extension-PCR.
 For C<sub>158</sub>-CFP and C<sub>116</sub>-CFP, 5â²-EcoRI* and
 3â²-BamHI* restriction sites were introduced to flanking nucleotide
 sequences corresponding to Ca<sub>V</sub>1.3 amino acid positions
 1980â2137 and 2022â2137 and cloned into EcoRI-BamHI-cut vector
 <italic>pECFP-N1</italic>. To generate enhanced CFP-C<sub>116</sub><sup>DEQQ</sup>,
 aspartate and glutamate at positions 2073 and 2076 were mutated to glutamines
 by splicing by overlapping extension-PCR. Integrity of all constructs was
 confirmed by DNA sequencing (MWG Biotec, Martinsried, Germany). Construct
 Ca<sub>V</sub>1.3<sub>42</sub> was subjected to full-length sequence analysis.
 Numbering of amino acids or nucleotide positions in all constructs refers to
 GenBankâ¢ accession number EU363339. Asterisks indicate artificial
 restriction sites introduced by PCR.</p>
      </sec>
      <sec>
        <title>Qualitative RT-PCR</title>
        <p>Mouse tissue was prepared from C57B/6N wild-type mice. Total RNA was
 isolated from whole-brain and brain sub-regions using the RNAqueosÂ®-4PCR
 kit (Ambion, Foster City, CA). After DNase I treatment, RNA integrity was
 checked by the quality of the 28 S and 18 S rRNA bands on a denaturing agarose
 gel. Organ of Corti mRNA was prepared from P4 or P19 mice as described in Ref.
 <xref ref-type="bibr" rid="ref23">23</xref>. Human total RNAs from
 brain, heart, pancreas, and retina were purchased from Clontech. One Î¼g of
 total RNA was used for first strand cDNA synthesis by reverse transcriptase
 (RevertAidâ¢ H Minus First Strand cDNA synthesis kit, MBI; Fermentas,
 Hanover, Germany) and random hexamer primers. For PCR analysis, the forward
 (fwd) primer was located in exon 39 (GenBankâ¢ accession number NM_028981
 for mouse and EU363339 for human). To differentiate between
 Ca<sub>V</sub>1.3<sub>42</sub> and Ca<sub>V</sub>1.3<sub>42A</sub>, specific
 reverse (rev) primers were designed, located either in exon 42 or 42A. The
 following primers were used for mouse: fwd primer,
 5â²-CAACCCTGTTTGCTTTGGTC-3â², and rev primer for exon 42,
 5â²TATAGCCCGTCGGATTTCTG-3â² (332-bp product); rev primer for exon
 42A, 5â²-CTTCCTTCCGGAGGAGTGC-3â² (483-bp product). The following
 primers were used for human: fwd primer,
 5â²-AACCCTGTTTGCTTTGGTTC-3â², rev primer for exon 42,
 5â²-TATAGCACGCCGGATTTCTG-3â² (331-bp product); rev primer for exon
 42A, 5â²-CCACCTTCCGGAGGAGTG-3â² (488-bp product). In mouse organ of
 Corti, splice variants were also detected with the following primer pairs:
 exon 42 fwd primer, 5â²-CTGCTTGACCAAGTTGTCCCTCCA-3â², rev primer,
 5â²-CTACAAGGTGGTAATGCAAATCAT-3â²; exon 42A, fwd primer,
 5â²-CGCGGATCCTACTTGACCAAGTTGTCCC-3â²; rev primer,
 5â²-CGCAAGCTTCTAGAGCATCCGTTCAAGC-3â². Mouse and human GAPDH was used
 as positive control as follows: for mouse (GenBankâ¢ accession number
 NM_008084), fwd primer, 5â²-ACTCCACTCACGGCAAATTC-3â², rev primer
 5â²-CACATTGGGGGTAGGAACAC-3â² (572-bp product); for human
 (GenBankâ¢ accession number NM_002046), fwd primer, CAATGACCCCTTCATTGACC,
 rev primer, 5â²-GAGGCAGGGATGATGTTCTG-3â² (531-bp product). 500 ng
 (2.7 Î¼g for organ of Corti) of reverse-transcribed cDNA was used as
 template for each PCR. Samples without template were used as contamination
 control. The following PCR program was used: 94 Â°C for 3 min, 40 cycles of
 94 Â°C for 45 s, 55 Â°C for 45 s, and 68 Â°C for 1 min, followed by
 an elongation step of 68 Â°C for 10 min. PCRs were performed using
 BioThermâ¢ TaqDNA polymerase (GeneCraft, LÃ¼dinghausen, Germany) in
 the presence of 1.5 m<sc>m</sc> MgCl<sub>2</sub>. The resulting PCR products
 were subcloned into pGEM-T Easy vectors (Promega, Mannheim, Germany) and
 sequenced.</p>
      </sec>
      <sec>
        <title>Quantitative RT-PCR</title>
        <p><italic>RNA Isolation and cDNA Preparation</italic>âTissue from three adult
 male c57BL/6N mice (3â6 months) was used for whole-brain and brain
 sub-region cDNA preparations. Total RNA and cDNA were prepared as described
 (<xref ref-type="bibr" rid="ref24">24</xref>).</p>
        <p><italic>Quantitative RT-PCR</italic>âThe relative abundance of different
 Ca<sub>V</sub>1.3 mRNAs was assessed by TaqMan quantitative PCR (50 cycles)
 using a standard curve method as described
 (<xref ref-type="bibr" rid="ref24">24</xref>). TaqMan gene expression
 assays, designed to span exon-exon boundaries, were purchased from Applied
 Biosystems (Foster City, CA). Assessment of mouse GAPDH transcripts was
 included as efficiency reference. Assay identification numbers are as follows:
 exon 42, Mm0551393_m1 (efficiency (<italic>E</italic>) = 103.6%); exon 42A (<italic>E</italic>
 = 98.7%), custom-designed (fwd primer,
 5â²-GGAAGTACCCTGCGAAGAACAC-3â²; probe,
 5â²-TTGCCCTACAGATGCTTG-3â²; rev primer,
 5â²-CTCAGGCAGAGAACTCTAAAGCAT-3â²); GAPDH, Mm99999915_g1. To amplify
 specific cDNA templates from the analyzed tissues for the standard curves of
 each assay, primer pairs were as follows: exon 42 fwd primer,
 5â²-CAACCCTGTTTGCTTTGGTC-3â², rev primer,
 5â²-TGATTGACATGGTTTCCAAGC-3â²; exon 42A fwd primer,
 5â²-CAACCCTGTTTGCTTTGGTC-3â², rev primer,
 5â²-CTTCCTTCCGGAGGAGTGC-3â². Analysis was carried out in
 triplicate.</p>
        <p><italic>Cell Culture and Transient Expression</italic>âHEK-293 (tsA-201)
 cells were cultured and transfected as described previously
 (<xref ref-type="bibr" rid="ref4">4</xref>). Untagged
 Ca<sub>V</sub>1.3Î±1 constructs were expressed together with Î²3 (or
 Î²2a) and Î±<sub>2</sub>Î´ 1 subunits
 (<xref ref-type="bibr" rid="ref4">4</xref>). In co-expression studies,
 GFP-labeled C-terminal Ca<sub>V</sub>1.3 fragments were used to ensure the
 presence of the corresponding C-terminal peptide in the cell recorded.
 Immunoblotting was performed as described previously
 (<xref ref-type="bibr" rid="ref25">25</xref>) using a generic
 anti-Î±1 sequence-directed antibody as described previously
 (<xref ref-type="bibr" rid="ref4">4</xref>). All constructs were
 expressed with the expected molecular mass.</p>
        <p><italic>Electrophysiological Recordings</italic>âWhole-cell patch clamp
 recordings in transiently transfected HEK-293 (tsA-201) cells were performed
 2â3 days after transfection using either 15 m<sc>m</sc>
 Ba<sup>2+</sup> or Ca<sup>2+</sup> as charge carrier as described in Ref.
 <xref ref-type="bibr" rid="ref4">4</xref>. Recording solutions were
 composed as follows (in m<sc>m</sc>): intracellular solution, 135 CsCl, 10
 Cs-EGTA, 1 MgCl<sub>2</sub> adjusted to pH 7.4 with CsOH (311
 mos<sc>m</sc>); bath solution, 15 BaCl<sub>2</sub>, 10 HEPES, 150
 choline-Cl, and 1 MgCl<sub>2</sub>, adjusted to pH 7.4 with CsOH (358
 mos<sc>m</sc>). Transfected cells were visualized by co-expression of GFP or
 GFP- or YFP-labeled constructs co-expressed with the channel complex as
 indicated. Current-voltage (<italic>I-V</italic>) relationships were obtained by
 holding cells at a potential of â90 mV before applying 50-ms or 300-ms
 pulses to various test potentials. <italic>I-V</italic> curves were fitted to the
 equation <italic>I</italic> = <italic>G</italic><sub>max</sub>(<italic>V</italic> â
 <italic>V</italic><sub>rev</sub>)/{1 + exp((<italic>V</italic> â
 <italic>V</italic><sub>0.5act</sub>)/<italic>k</italic>)}, where <italic>V</italic><sub>rev</sub> is
 the extrapolated reversal potential; <italic>V</italic> is the test potential;
 <italic>I</italic> is the peak current amplitude; <italic>G</italic><sub>max</sub> is the
 maximum slope conductance; <italic>V</italic><sub>0.5,act</sub> is the half-maximal
 activation voltage; and <italic>k</italic> is the slope factor. Percentage of
 inactivation was determined at specified time points during depolarizing
 pulses from a holding potential of â90 mV to the peak current potential
 (<italic>V</italic><sub>max</sub>) of the <italic>IâV</italic> relation of the
 individual cell. The voltage dependence of inactivation was assessed by
 application of a 20-ms test pulse to <italic>V</italic><sub>max</sub> before and after
 holding cells at various conditioning test potentials for 5 s. Steady-state
 inactivation curves were analyzed using the Boltzmann relationship <italic>I</italic>
 = <italic>I<sub>SS</sub></italic> + (1 â <italic>I<sub>SS</sub></italic>)/(1 +
 exp(<italic>V</italic> â
 <italic>V</italic><sub>0.5,inact</sub>/<italic>k</italic><sub>inact</sub>)), where <italic>I</italic>
 is the peak current amplitude; <italic>I<sub>SS</sub></italic> is the noninactivating
 fraction; <italic>V</italic> is the membrane potential; <italic>V</italic><sub>0.5,inact</sub>
 is the half-inactivation potential; and <italic>k</italic><sub>inact</sub> is the
 slope factor. To investigate Ca<sub>V</sub>1.3<sub>42</sub> and
 Ca<sub>V</sub>1.3<sub>42A</sub> gating properties, head-to-head analysis was
 performed time-independently by two investigators. Experiments showing
 currents bigger than 3 nA were prospectively excluded from analysis of
 activation and inactivation parameters to guarantee high quality voltage
 clamp. CDI was quantified as the current remaining at the end of 250-ms
 depolarizations to different test potentials, expressed as fraction of peak
 current amplitude (<italic>r</italic><sub>250</sub>). Parameter <italic>f</italic> was defined
 as the difference between <italic>r</italic><sub>250</sub> values of
 <italic>I</italic><sub>Ba</sub> and <italic>I</italic><sub>Ca</sub> at +10 mV. CDI experiments
 were performed on different cells, but effects were the same when the charge
 carrier was switched from Ba<sup>2+</sup> to Ca<sup>2+</sup> on the same cell
 in representative experiments. All voltages were corrected for the liquid
 junction potential.</p>
      </sec>
      <sec>
        <title>Confocal FRET Microscopy</title>
        <p>Confocal FRET microscopy was performed as described previously
 (<xref ref-type="bibr" rid="ref15">15</xref>). As negative controls,
 peptide <italic>YFP</italic>-EF-PreIQ-IQ-PCRD was co-expressed with CFP alone (CFP
 control), and probes <italic>CFP</italic>-C<sub>158</sub> or
 <italic>CFP</italic>-C<sub>116</sub> with YFP alone (YFP controls 1 and 2). Image
 analysis was accomplished using a self-made program integrated in MatLab 7
 based on the FRET analysis algorithm proposed
 (<xref ref-type="bibr" rid="ref26">26</xref>). Interaction between
 fragments was considered when a significant difference to the CFP as well as
 the corresponding YFP control was observed. The local ratio between CFP and
 YFP might vary because of different local expression levels of the different
 protein constructs, which could affect calculation of FRET values. Therefore,
 analysis was limited to pixels with a CFP:YFP molar ratio between 1:10 and
 10:1.</p>
      </sec>
      <sec>
        <title>Statistical Analysis</title>
        <p>Data were analyzed using ClampfitÂ® 9.0 (Molecular Devices, Union City,
 CA) and Microcal OriginÂ® 5.0 (Northampton, MA). Significant difference
 between the two splice variants was assessed <italic>a priori</italic> by pairwise
 comparison before other truncation constructs to characterize the modulatory
 mechanism were made. Student's <italic>t</italic> test or Mann-Whitney test were used
 for comparison between two groups for parametric and nonparametric data,
 respectively. Statistical significance was determined using one-way ANOVA
 followed by Bonferroni post-test, except if stated otherwise. Statistical
 significance was set at <italic>p</italic> &lt; 0.05. All data are presented as mean
 Â± S.E. for the indicated number of experiments.</p>
      </sec>
    </sec>
    <sec>
      <title>RESULTS</title>
      <p><italic>Ca<sub>V</sub>1.3 C-terminal Modulator Affects Voltage-dependent
 Channel Activity</italic>âTo test for the presence of a C-terminal modulator
 (CTM), we employed two previously described naturally occurring
 Ca<sub>V</sub>1.3 Î±1 subunit splice variants,
 Ca<sub>V</sub>1.3<sub>42</sub> and Ca<sub>V</sub>1.3<sub>42A</sub> (also
 termed Ca<sub>V</sub>1.3a and Ca<sub>V</sub>1.3b, respectively
 (<xref ref-type="bibr" rid="ref5">5</xref>,
 <xref ref-type="bibr" rid="ref27">27</xref>,
 <xref ref-type="bibr" rid="ref28">28</xref>)), which differ with
 respect to the length of their C termini, as illustrated in
 <xref ref-type="fig" rid="fig1">Fig. 1<italic>a</italic></xref>. Similar to
 the Ca<sub>V</sub>1.4 truncation mutant K1591<italic>X</italic>
 (<xref ref-type="bibr" rid="ref15">15</xref>),
 Ca<sub>V</sub>1.3<sub>42A</sub> terminates shortly after the IQ motif and
 lacks most of a homologous region (termed PCRD) previously found to
 participate in the binding of distal C-terminal sequences in Ca<sub>V</sub>1.2
 (<xref ref-type="bibr" rid="ref17">17</xref>). Wild-type long and short
 Ca<sub>V</sub>1.3 Î±1 subunits were expressed in HEK-293 cells together
 with Î²3 (or Î²2a) and Î±2Î´ 1. Î²3 subunits were
 selected because we have previously shown that they form a large fraction of
 dihydropyridine-sensitive LTCCs in the brain
 (<xref ref-type="bibr" rid="ref29">29</xref>). Both Î±1 subunits
 migrated with the expected molecular mass in Western blots of HEK-293 cell
 preparations (<xref ref-type="fig" rid="fig1">Fig.
 1<italic>b</italic></xref>).</p>
      <p>
        <fig position="float" id="fig1">
          <label>FIGURE 1.</label>
          <caption>
            <p><bold>C-terminal splice variants Ca<sub>V</sub>1.3<sub>42</sub> and
 Ca<sub>V</sub>1.3<sub>42A</sub>.</bold> <italic>a,</italic> alternative usage of exon 42
 results in either full-length (exon 42, <italic>black</italic>) or C-terminally
 truncated (exon 42A, <italic>gray</italic>) Ca<sub>V</sub>1.3 channels.
 <italic>Arrows</italic> indicate the approximate position of forward (<italic>fwd</italic>)
 and reverse (<italic>rev</italic>) PCR primers used in
 <xref ref-type="fig" rid="fig8">Fig. 8</xref>. <italic>b,</italic> immunoblot
 of both splice variants expressed together with Î²3 and Î±2Î´1
 subunits in HEK-293 cells, as described under âExperimental
 Procedures.â Mock-transfected cells (<italic>mock</italic>) were used to show
 specificity of immunoreactivity. One representative experiment out of four is
 shown.</p>
          </caption>
          <graphic xlink:href="zbc0310843690001"/>
        </fig>
      </p>
      <p>
        <fig position="float" id="fig2">
          <label>FIGURE 2.</label>
          <caption>
            <p><bold>Activation and steady-state inactivation properties of
 Ca<sub>V</sub>1.3<sub>42</sub> compared with Ca<sub>V</sub>1.3<sub>42A</sub>
 channels.</bold> <italic>a,</italic> normalized mean <italic>I</italic>-<italic>V</italic> curves of
 <italic>I</italic><sub>Ca</sub> for Ca<sub>V</sub>1.3<sub>42</sub> (<italic>black</italic>)
 and Ca<sub>V</sub>1.3<sub>42A</sub> (<italic>gray</italic>) channels. Activation
 parameters and statistics are given in
 <xref ref-type="table" rid="tbl1">Table 1</xref>. The <italic>dotted
 line</italic> describes the fit to a normalized <italic>I-V</italic> curve of
 <italic>I</italic><sub>Ca</sub> for Ca<sub>V</sub>1.2 in comparison:
 <italic>V</italic><sub>0.5,act</sub>, 8.8 mV; <italic>k</italic><sub>act</sub>, â11.0
 mV. Cell, 111d_16. <italic>b,</italic> representative current traces for
 <italic>I</italic><sub>Ca</sub> (300-ms depolarization to indicated test potentials).
 Cells: Ca<sub>V</sub>1.3<sub>42</sub>, 196l_23;
 Ca<sub>V</sub>1.3<sub>42A</sub>, 196l_32. <italic>c, V</italic><sub>0.5,act</sub> for
 Ca<sub>V</sub>1.3<sub>42A</sub> was independent from current density.
 <italic>d,</italic> exemplar ON-gating currents for Ca<sub>V</sub>1.3<sub>42</sub> and
 Ca<sub>V</sub>1.3<sub>42A</sub> with similar <italic>I</italic><sub>Ba</sub>
 amplitudes measured by depolarizing cells to <italic>V</italic><sub>rev</sub>. One
 representative out of six experiments is shown. Cells:
 Ca<sub>V</sub>1.3<sub>42</sub>, 207l_34; Ca<sub>V</sub>1.3<sub>42A</sub>,
 237k_26. <italic>e,</italic> steady-state inactivation curves for
 Ca<sub>V</sub>1.3<sub>42</sub> and Ca<sub>V</sub>1.3<sub>42A</sub>. Activation
 curves were obtained from parameters in <italic>a. Solid lines</italic> are fits to
 the Boltzmann relationship (see âExperimental Proceduresâ).
 Statistics are given under âResults.â <italic>Error bars</italic> reflect
 S.E.</p>
          </caption>
          <graphic xlink:href="zbc0310843690002"/>
        </fig>
      </p>
      <p>We systematically investigated the biophysical properties of both
 <italic>I</italic><sub>Ca</sub> and <italic>I</italic><sub>Ba</sub> for
 Ca<sub>V</sub>1.3<sub>42</sub> and Ca<sub>V</sub>1.3<sub>42A</sub> as
 illustrated in Figs. <xref ref-type="fig" rid="fig2">2</xref> and
 <xref ref-type="fig" rid="fig3">3</xref> and Tables
 <xref ref-type="table" rid="tbl1">1</xref>,
 <xref ref-type="table" rid="tbl2">2</xref>,
 <xref ref-type="table" rid="tbl3">3</xref>. The voltage dependence of
 <italic>I</italic><sub>Ca</sub> activation of Ca<sub>V</sub>1.3<sub>42A</sub> was
 significantly shifted to hyperpolarizing potentials by about 10 mV
 (Ca<sub>V</sub>1.3<sub>42</sub>: <italic>V</italic><sub>0.5,act</sub> = â2.2
 Â± 0.6 mV, <italic>n</italic> = 14; Ca<sub>V</sub>1.3<sub>42A</sub>:
 <italic>V</italic><sub>0.5,act</sub> = â12.9 Â± 0.8 mV, <italic>n</italic> = 15;
 <italic>p</italic> &lt; 0.001; see <xref ref-type="table" rid="tbl1">Table
 1</xref>). This negative shift was because of the significant decrease in
 <italic>k</italic><sub>act</sub> (Ca<sub>V</sub>1.3<sub>42</sub>: â9.1 Â±
 0.2, <italic>n</italic> = 14; Ca<sub>V</sub>1.3<sub>42A</sub>: â6.9 Â±
 0.2, <italic>n</italic> = 15; <italic>p</italic> &lt; 0.001; see
 <xref ref-type="table" rid="tbl1">Table 1</xref>) without change in the
 activation threshold (<xref ref-type="fig" rid="fig2">Fig.
 2<italic>a</italic></xref>). Such changes were also observed for
 <italic>I</italic><sub>Ba</sub> (<xref ref-type="table" rid="tbl2">Table
 2</xref>). The negative activation range persisted when subgroups of
 cells with different current amplitudes (0.1â0.6 <italic>versus</italic>
 0.7â2.3 nA) were compared (<xref ref-type="fig" rid="fig2">Fig.
 2<italic>c</italic></xref>). It was not restricted to Î²3 subunit-containing
 channel complexes because it was also seen when the Ca<sub>V</sub>1.3 splice
 variants were co-expressed with Î²2a subunits
 (<italic>V</italic><sub>0.5,act</sub>, <italic>I</italic><sub>Ca</sub>,
 Ca<sub>V</sub>1.3<sub>42</sub>, <italic>V</italic><sub>0.5,act</sub>, 0.06 Â±
 3.2 mV, <italic>n</italic> = 3, Ca<sub>V</sub>1.3<sub>42A</sub>,
 <italic>V</italic><sub>0.5,act</sub>, â11.2 Â± 1.7 mV<sub>,</sub>
 <italic>n</italic> = 3; <italic>I</italic><sub>Ba</sub>, Ca<sub>V</sub>1.3<sub>42</sub>,
 â12.5 Â± 1.6 mV, <italic>n</italic> = 7, Ca<sub>V</sub>1.3<sub>42A</sub>,
 â22.7 Â± 1.3 mV, <italic>n</italic> = 6). Mean current density of
 Ca<sub>V</sub>1.3<sub>42A</sub> channels was â¼2.5-fold higher for
 <italic>I</italic><sub>Ca</sub> (Ca<sub>V</sub>1.3<sub>42</sub>, 21.0 Â± 3.3
 pA/pF, <italic>n</italic> = 14; Ca<sub>V</sub>1.3<sub>42A</sub>, 98.3 Â± 31.8,
 <italic>n</italic> = 19, <italic>p</italic> &lt; 0.01, Mann-Whitney test). A similar increase
 was observed for <italic>I</italic><sub>Ba</sub> (not shown). Increased current
 density occurred without detectable changes in the expression density as
 observed in immunoblots (<xref ref-type="fig" rid="fig1">Fig.
 1<italic>b</italic></xref><italic>, n</italic> = 4). Depolarization to the reversal
 potential (<italic>V</italic><sub>rev</sub>) revealed a small ON-gating current which
 was always detectable for Ca<sub>V</sub>1.3<sub>42</sub> channels but was
 absent (or much reduced) in Ca<sub>V</sub>1.3<sub>42A</sub> currents
 (<xref ref-type="fig" rid="fig2">Fig. 2<italic>d</italic></xref>). This
 further suggests that the larger current amplitude of
 Ca<sub>V</sub>1.3<sub>42A</sub> channels was not because of an increased
 expression density of channels at the plasma membrane in line with the
 immunoblot analysis.</p>
      <p>
        <table-wrap position="float" id="tbl1">
          <label>TABLE 1</label>
          <caption>
            <p>Biophysical ICa properties of
 CaV1.342 and CaV1.342A channels in
 comparison with different C-terminally truncated CaV1.3 channel
 constructs</p>
            <p>Number of experiments is indicated in parentheses.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="center">
                  <bold>Construct</bold>
                </th>
                <th valign="top" align="center">
                  <bold>
                    <italic>V</italic>
                    <sub>0.5,act</sub>
                  </bold>
                </th>
                <th valign="top" align="center">
                  <bold>
                    <italic>k</italic>
                    <sub>act</sub>
                  </bold>
                </th>
                <th valign="top" align="center">
                  <bold>
                    <italic>V</italic>
                    <sub>max</sub>
                  </bold>
                </th>
                <th valign="top" align="center">
                  <bold>Activation threshold</bold>
                </th>
                <th valign="top" align="center">
                  <bold>
                    <italic>V</italic>
                    <sub>rev</sub>
                  </bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="top"/>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42</sub> (14)
 </td>
                <td align="center" valign="top"> -2.2 Â±
 0.6<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -9.1 Â±
 0.2<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> 13.3 Â±
 0.6<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -35.6 Â± 0.7
 </td>
                <td align="center" valign="top"> 69.8 Â± 1.1
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42A</sub> (15)
 </td>
                <td align="center" valign="top"> -12.9 Â±
 0.8<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -6.9 Â±
 0.2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> 1.9 Â±
 0.9<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -37.1 Â± 0.8
 </td>
                <td align="center" valign="top"> 65.7 Â± 1.1
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC158</sub> (9)
 </td>
                <td align="center" valign="top"> -14.3 Â±
 0.4<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -7.4 Â±
 0.2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> 0.7 Â±
 0.5<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -38.9 Â±
 0.6<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
                <td align="center" valign="top"> 62.4 Â±
 1.3<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC116</sub> (10)
 </td>
                <td align="center" valign="top"> -12.0 Â±
 0.7<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -7.7 Â±
 0.3<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td>
                <td align="center" valign="top"> 3.0 Â±
 0.8<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -38.4 Â± 0.5
 </td>
                <td align="center" valign="top"> 61.4 Â±
 1.1<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC76</sub> (12)
 </td>
                <td align="center" valign="top"> -14.6 Â±
 0.9<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -7.0 Â±
 0.3<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> 0.8 Â±
 1.2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -38.1 Â± 0.4
 </td>
                <td align="center" valign="top"> 63.5 Â±
 1.3<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC473</sub> (9)
 </td>
                <td align="center" valign="top"> -12.8 Â±
 1.4<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -7.3 Â±
 0.4<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> 2.1 Â±
 1.7<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -37.1 Â± 1.1
 </td>
                <td align="center" valign="top"> 64.7 Â± 1.3
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42A</sub> + C<sub>158</sub> (7)
 </td>
                <td align="center" valign="top"> -12.6 Â±
 1.5<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -7.6 Â±
 0.3<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td>
                <td align="center" valign="top"> 2.8 Â±
 1.5<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -38.9 Â± 0.7
 </td>
                <td align="center" valign="top"> 63.6 Â±
 2.2<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC158</sub> + C<sub>158</sub> (8)
 </td>
                <td align="center" valign="top"> -0.8 Â±
 1.4<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -9.7 Â±
 0.4<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> 13.9 Â±
 1.2<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -36.5 Â± 0.9
 </td>
                <td align="center" valign="top"> 67.5 Â± 1.2
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC116</sub> + C<sub>116</sub> (7)
 </td>
                <td align="center" valign="top"> -4.2 Â±
 0.7<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -9.1 Â±
 0.4<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> 10.0 Â±
 0.6<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -38.2 Â± 0.9
 </td>
                <td align="center" valign="top"> 61.5 Â±
 1.3<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC76</sub> + C<sub>76</sub> (11)
 </td>
                <td align="center" valign="top"> -13.8 Â±
 0.9<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -7.1 Â±
 0.2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> 1.5 Â±
 1.2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -37.2 Â± 0.7
 </td>
                <td align="center" valign="top"> 61.5 Â±
 1.3<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top">
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> + C<sub>116</sub> (9)
 </td>
                <td align="center" valign="top">
 -3.1 Â±
 1.4<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top">
 -9.1 Â±
 0.3<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top">
 11.7 Â±
 1.2<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
                <td align="center" valign="top">
 -35.7 Â± 0.3
 </td>
                <td align="center" valign="top">
 65.4 Â± 0.9
 </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tblfn1">
              <label>a</label>
              <p>For statistics, <italic>p</italic> &lt; 0.001 compared with
 Ca<sub>V</sub>1.3<sub>42A</sub> (one-way ANOVA followed by Bonferroni
 post-test).</p>
            </fn>
            <fn id="tblfn2">
              <label>b</label>
              <p>Values are <italic>p</italic> &lt; 0.001 (statistically significant from
 Ca<sub>V</sub>1.3<sub>42</sub>).</p>
            </fn>
            <fn id="tblfn3">
              <label>c</label>
              <p>Values are <italic>p</italic> &lt; 0.05.</p>
            </fn>
            <fn id="tblfn4">
              <label>d</label>
              <p>Values are <italic>p</italic> &lt; 0.01.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </p>
      <p>
        <table-wrap position="float" id="tbl2">
          <label>TABLE 2</label>
          <caption>
            <p>Biophysical IBa properties of
 CaV1.342 and CaV1.342A channels in
 comparison with different C-terminally truncated CaV1.3 channel
 constructs</p>
            <p>Number of experiments is indicated in parentheses.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="center">
                  <bold>Construct</bold>
                </th>
                <th valign="top" align="center">
                  <bold>
                    <italic>V</italic>
                    <sub>0.5,act</sub>
                  </bold>
                </th>
                <th valign="top" align="center">
                  <bold>
                    <italic>k</italic>
                    <sub>act</sub>
                  </bold>
                </th>
                <th valign="top" align="center">
                  <bold>
                    <italic>V</italic>
                    <sub>max</sub>
                  </bold>
                </th>
                <th valign="top" align="center">
                  <bold>Activation threshold</bold>
                </th>
                <th valign="top" align="center">
                  <bold>
                    <italic>V</italic>
                    <sub>rev</sub>
                  </bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="top"/>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
                <td align="center" valign="top">
                  <italic>mV</italic>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42</sub> (18)
 </td>
                <td align="center" valign="top"> -11.8 Â±
 0.9<xref ref-type="table-fn" rid="tblfn5"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -7.8 Â±
 0.2<xref ref-type="table-fn" rid="tblfn6"><italic>b</italic></xref></td>
                <td align="center" valign="top"> 3.4 Â±
 0.9<xref ref-type="table-fn" rid="tblfn6"><italic>b</italic></xref></td>
                <td align="center" valign="top"> -39.9 Â±
 0.7<xref ref-type="table-fn" rid="tblfn6"><italic>b</italic></xref></td>
                <td align="center" valign="top"> 58.2 Â±
 0.9<xref ref-type="table-fn" rid="tblfn5"><italic>a</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42A</sub> (12)
 </td>
                <td align="center" valign="top"> -20.2 Â±
 1.0<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -6.6 Â±
 0.3<xref ref-type="table-fn" rid="tblfn8"><italic>d</italic></xref></td>
                <td align="center" valign="top"> -6.6 Â±
 1.2<xref ref-type="table-fn" rid="tblfn8"><italic>d</italic></xref></td>
                <td align="center" valign="top"> -43.3 Â±
 0.6<xref ref-type="table-fn" rid="tblfn8"><italic>d</italic></xref></td>
                <td align="center" valign="top"> 50.7 Â±
 1.6<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC158</sub> (12)
 </td>
                <td align="center" valign="top"> -20.9 Â±
 1.2<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -5.7 Â±
 0.3<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -8.4 Â±
 1.5<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -41.7 Â± 0.5
 </td>
                <td align="center" valign="top"> 46.4 Â±
 1.6<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC116</sub> (9)
 </td>
                <td align="center" valign="top"> -22.9 Â±
 0.6<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -5.9 Â±
 0.2<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -10.3 Â±
 0.8<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -43.7 Â±
 0.5<xref ref-type="table-fn" rid="tblfn8"><italic>d</italic></xref></td>
                <td align="center" valign="top"> 44.2 Â±
 1.2<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref><sup>,</sup><xref ref-type="table-fn" rid="tblfn9"><italic>e</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC76</sub> (10)
 </td>
                <td align="center" valign="top"> -22.8 Â±
 0.5<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -5.5 Â±
 0.1<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -9.9 Â±
 0.6<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -41.9 Â± 0.4
 </td>
                <td align="center" valign="top"> 48.1 Â±
 0.8<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC473</sub> (6)
 </td>
                <td align="center" valign="top"> -22.2 Â±
 0.9<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -5.9 Â±
 0.1<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -8.9 Â±
 1.0<xref ref-type="table-fn" rid="tblfn8"><italic>d</italic></xref></td>
                <td align="center" valign="top"> -42.2 Â± 0.7
 </td>
                <td align="center" valign="top"> 49.1 Â±
 0.7<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42A</sub> + C<sub>158</sub> (7)
 </td>
                <td align="center" valign="top"> -22.2 Â±
 1.2<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -6.1 Â±
 0.4<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -8.8 Â±
 1.5<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -44.1 Â±
 0.9<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> 48.8 Â±
 1.1<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC158</sub> + C<sub>158</sub> (11)
 </td>
                <td align="center" valign="top"> -10.3 Â±
 0.9<xref ref-type="table-fn" rid="tblfn5"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -8.2 Â±
 0.2<xref ref-type="table-fn" rid="tblfn5"><italic>a</italic></xref></td>
                <td align="center" valign="top"> 3.6 Â±
 0.8<xref ref-type="table-fn" rid="tblfn5"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -40.1 Â±
 0.7<xref ref-type="table-fn" rid="tblfn9"><italic>e</italic></xref></td>
                <td align="center" valign="top"> 56.4 Â±
 1.2<xref ref-type="table-fn" rid="tblfn9"><italic>e</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC116</sub> + C<sub>116</sub> (7)
 </td>
                <td align="center" valign="top"> -13.3 Â±
 1.2<xref ref-type="table-fn" rid="tblfn5"><italic>a</italic></xref></td>
                <td align="center" valign="top"> -7.8 Â±
 0.2<xref ref-type="table-fn" rid="tblfn9"><italic>e</italic></xref></td>
                <td align="center" valign="top"> 1.2 Â± 1.2
 </td>
                <td align="center" valign="top"> -41.2 Â± 0.9
 </td>
                <td align="center" valign="top"> 54.9 Â± 1.3
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC76</sub> + C<sub>76</sub> (9)
 </td>
                <td align="center" valign="top"> -22.1 Â±
 0.8<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -5.9 Â±
 0.2<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -7.5 Â±
 1.3<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
                <td align="center" valign="top"> -42.6 Â± 0.6
 </td>
                <td align="center" valign="top"> 49.2 Â±
 1.2<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
              </tr>
              <tr>
                <td align="left" valign="top">
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> + C<sub>116</sub> (11)
 </td>
                <td align="center" valign="top">
 -15.6 Â±
 1.2<xref ref-type="table-fn" rid="tblfn9"><italic>e</italic></xref></td>
                <td align="center" valign="top">
 -7.6 Â±
 0.1<xref ref-type="table-fn" rid="tblfn9"><italic>e</italic></xref></td>
                <td align="center" valign="top">
 -1.7 Â±
 1.1<xref ref-type="table-fn" rid="tblfn8"><italic>d</italic></xref><sup>,</sup><xref ref-type="table-fn" rid="tblfn9"><italic>e</italic></xref></td>
                <td align="center" valign="top">
 -42.9 Â±
 0.8<xref ref-type="table-fn" rid="tblfn8"><italic>d</italic></xref></td>
                <td align="center" valign="top">
 50.8 Â±
 0.8<xref ref-type="table-fn" rid="tblfn7"><italic>c</italic></xref></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tblfn5">
              <label>a</label>
              <p>For statistics, <italic>p</italic> &lt; 0.001 compared with
 Ca<sub>V</sub>1.3<sub>42A</sub> (for multiple comparison test, see
 <xref ref-type="table" rid="tbl1">Table 1</xref>).</p>
            </fn>
            <fn id="tblfn6">
              <label>b</label>
              <p>Values are <italic>p</italic> &lt; 0.01.</p>
            </fn>
            <fn id="tblfn7">
              <label>c</label>
              <p>Values are <italic>p</italic> &lt; 0.001 (statistically significant from
 Ca<sub>V</sub>1.3<sub>42</sub>).</p>
            </fn>
            <fn id="tblfn8">
              <label>d</label>
              <p>Values are <italic>p</italic> &lt; 0.01.</p>
            </fn>
            <fn id="tblfn9">
              <label>e</label>
              <p>Values are <italic>p</italic> &lt; 0.05.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </p>
      <p>
        <table-wrap position="float" id="tbl3">
          <label>TABLE 3</label>
          <caption>
            <p>ICa and IBa inactivation and CDI
 properties of CaV1.342 and
 CaV1.342A channels in comparison with different
 C-terminally truncated CaV1.3 channel constructs</p>
            <p>Number of experiments is indicated in parentheses.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="center">
                  <bold>Construct</bold>
                </th>
                <th valign="top" align="center">
                  <bold><italic>I</italic><sub>Ca</sub> inactivation during 30 ms</bold>
                </th>
                <th valign="top" align="center">
                  <bold><italic>I</italic><sub>Ba</sub> inactivation during 250 ms</bold>
                </th>
                <th valign="top" align="center">
                  <bold><italic>f</italic> value, <italic>n</italic> = 6-11</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="top"/>
                <td align="center" valign="top"> %
 </td>
                <td align="center" valign="top"> %
 </td>
                <td align="center" valign="top"/>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42</sub></td>
                <td align="center" valign="top"> 27.5 Â±
 1.9<xref ref-type="table-fn" rid="tblfn10"><italic>a</italic></xref>
 (16)
 </td>
                <td align="center" valign="top"> 39.8 Â±
 1.6<xref ref-type="table-fn" rid="tblfn10"><italic>a</italic></xref>
 (8)
 </td>
                <td align="center" valign="top"> 0.25 Â± 0.11
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42A</sub></td>
                <td align="center" valign="top"> 73.6 Â±
 1.9<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (19)
 </td>
                <td align="center" valign="top"> 21.1 Â±
 3.8<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (14)
 </td>
                <td align="center" valign="top"> 0.60 Â± 0.07
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC158</sub></td>
                <td align="center" valign="top"> 70.4 Â±
 2.2<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (8)
 </td>
                <td align="center" valign="top"> 16.9 Â±
 3.5<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (7)
 </td>
                <td align="center" valign="top"> 0.60 Â± 0.05
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC116</sub></td>
                <td align="center" valign="top"> 72.6 Â±
 1.5<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (8)
 </td>
                <td align="center" valign="top"> 8.5 Â±
 1.9<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>,<xref ref-type="table-fn" rid="tblfn12"><italic>c</italic></xref>
 (9)
 </td>
                <td align="center" valign="top"> 0.66 Â± 0.05
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC76</sub></td>
                <td align="center" valign="top"> 74.3 Â±
 1.8<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (9)
 </td>
                <td align="center" valign="top"> 14.9 Â±
 1.9<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (11)
 </td>
                <td align="center" valign="top"> 0.72 Â± 0.04
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC473</sub></td>
                <td align="center" valign="top"> 71.7 Â±
 1.3<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (7)
 </td>
                <td align="center" valign="top"> 15.9 Â±
 2.9<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (8)
 </td>
                <td align="center" valign="top"> 0.67 Â± 0.06
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>42A</sub> + C<sub>158</sub></td>
                <td align="center" valign="top"> 67.1 Â±
 2.5<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (6)
 </td>
                <td align="center" valign="top"> 10.3 Â±
 1.3<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (5)
 </td>
                <td align="center" valign="top"> 0.71 Â± 0.06
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC158</sub> + C<sub>158</sub></td>
                <td align="center" valign="top"> 23.5 Â±
 1.9<xref ref-type="table-fn" rid="tblfn10"><italic>a</italic></xref>
 (8)
 </td>
                <td align="center" valign="top"> 30.2 Â± 2.5 (12)
 </td>
                <td align="center" valign="top"> 0.20 Â± 0.08
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC116</sub> + C<sub>116</sub></td>
                <td align="center" valign="top"> 34.8 Â±
 2.0<xref ref-type="table-fn" rid="tblfn12"><italic>c</italic></xref>
 (7)
 </td>
                <td align="center" valign="top"> 35.3 Â±
 2.7<xref ref-type="table-fn" rid="tblfn12"><italic>c</italic></xref>
 (7)
 </td>
                <td align="center" valign="top"> 0.29 Â± 0.05
 </td>
              </tr>
              <tr>
                <td align="left" valign="top"> Ca<sub>V</sub>1.3<sub>ÎC76</sub> + C<sub>76</sub></td>
                <td align="center" valign="top"> 67.2 Â±
 2.4<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (7)
 </td>
                <td align="center" valign="top"> 18.5 Â±
 2.6<xref ref-type="table-fn" rid="tblfn11"><italic>b</italic></xref>
 (9)
 </td>
                <td align="center" valign="top"> 0.56 Â± 0.06
 </td>
              </tr>
              <tr>
                <td align="left" valign="top">
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> + C<sub>116</sub></td>
                <td align="center" valign="top">
 32.2 Â±
 4.6<xref ref-type="table-fn" rid="tblfn10"><italic>a</italic></xref>
 (8)
 </td>
                <td align="center" valign="top">
 35.4 Â±
 1.9<xref ref-type="table-fn" rid="tblfn12"><italic>c</italic></xref>
 (9)
 </td>
                <td align="center" valign="top">
 0.27 Â± 0.05
 </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tblfn10">
              <label>a</label>
              <p>For statistics, <italic>p</italic> &lt; 0.001 compared with
 Ca<sub>V</sub>1.3<sub>42A</sub> (for multiple comparison test, see
 <xref ref-type="table" rid="tbl1">Table 1</xref>).</p>
            </fn>
            <fn id="tblfn11">
              <label>b</label>
              <p>Values are <italic>p</italic> &lt; 0.001 (statistically significant from
 Ca<sub>V</sub>1.3<sub>42</sub>).</p>
            </fn>
            <fn id="tblfn12">
              <label>c</label>
              <p>Values are <italic>p</italic> &lt; 0.01.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </p>
      <p>The short C terminus also resulted in a slight decrease of
 <italic>V</italic><sub>rev</sub> (with a larger and statistically significantly
 difference for <italic>I</italic><sub>Ba</sub>; see Tables
 <xref ref-type="table" rid="tbl1">1</xref> and
 <xref ref-type="table" rid="tbl2">2</xref>). The half-maximal voltage of
 steady-state inactivation (<italic>V</italic><sub>0.5,act</sub>) induced by 10-s
 conditioning pulses (<xref ref-type="fig" rid="fig2">Fig.
 2<italic>e</italic></xref>) for the physiological charge carrier was also
 significantly shifted toward more negative voltages in
 Ca<sub>V</sub>1.3<sub>42A</sub> channels (Ca<sub>V</sub>1.3<sub>42</sub>:
 â31.6 Â± 1.1 mV, <italic>n</italic> = 5; Ca<sub>V</sub>1.3<sub>42A</sub>:
 â38.8 Â± 1.6 mV, <italic>n</italic> = 4, <italic>p</italic> = 0.007, Student's
 <italic>t</italic> test). A significant difference in the slope factor
 (<italic>k</italic><sub>inact</sub>, Ca<sub>V</sub>1.3<sub>42</sub>: â6.4
 Â± 0.3 mV, <italic>n</italic> = 5; Ca<sub>V</sub>1.3<sub>42A</sub>: â4.9
 Â± 0.5 mV, <italic>n</italic> = 4, <italic>p</italic> = 0.03, Student's <italic>t</italic> test)
 was also observed. Theses changes in the voltage dependence of steady-state
 activation and inactivation resulted in a shift of the window current toward
 more hyperpolarizing voltages for Ca<sub>V</sub>1.3<sub>42A</sub>
 (<xref ref-type="fig" rid="fig2">Fig. 2<italic>e</italic></xref>). Our data
 demonstrate that the structural divergence within the C termini of these
 Ca<sub>V</sub>1.3 splice variants causes pronounced changes in channel gating
 suggesting the existence of a CTM in Ca<sub>V</sub>1.3 LTCCs that controls
 their activity at negative voltages.</p>
      <p><italic>Ca<sub>V</sub>1.3 C Terminus Modulates
 Ca<sup>2</sup></italic><sup>+</sup><italic>-dependent Inactivation
 Properties</italic>âAs already obvious from the representative current
 traces in <xref ref-type="fig" rid="fig2">Fig. 2<italic>b</italic></xref>,
 Ca<sub>V</sub>1.3<sub>42A</sub> channels inactivate faster during
 depolarization to different test potentials than
 Ca<sub>V</sub>1.3<sub>42</sub> channels. This is also evident from a detailed
 comparison of <italic>I</italic><sub>Ca</sub> inactivation during 10-s pulses to the
 maximum of the <italic>I-V</italic> curve (<italic>V</italic><sub>max</sub>)
 (<xref ref-type="fig" rid="fig3">Fig. 3, <italic>a</italic> and
 <italic>b</italic></xref>; <xref ref-type="table" rid="tbl3">Table
 3</xref>). The difference was most pronounced during the first 30 ms (%
 inactivation: Ca<sub>V</sub>1.3<sub>42</sub>, 27.5 Â± 1.9, <italic>n</italic> =
 16; Ca<sub>V</sub>1.3<sub>42A</sub>, 73.6 Â± 1.9, <italic>n</italic> = 19,
 <italic>p</italic> &lt; 0.001; <xref ref-type="fig" rid="fig3">Fig. 3, <italic>a,
 inset</italic>, and <italic>b</italic></xref>, and
 <xref ref-type="table" rid="tbl3">Table 3</xref>). Inactivation included
 an initial fast component followed by a slow component in both isoforms.
 Inactivation was not complete even during 10 s
 (Ca<sub>V</sub>1.3<sub>42</sub>, 96.9 Â± 0.7%, <italic>n</italic> = 14;
 Ca<sub>V</sub>1.3<sub>42A</sub>, 98.1 Â± 0.3%, <italic>n</italic> = 17; one
 sample <italic>t</italic> test, compared with 100%: <italic>p</italic> = 0.0006 for
 Ca<sub>V</sub>1.3<sub>42</sub> and <italic>p</italic> = 0.0001 for
 Ca<sub>V</sub>1.3<sub>42A</sub>) suggesting that some Ca<sup>2+</sup> influx
 through Ca<sub>V</sub>1.3 channels may persist even during extended periods of
 strong depolarization. Faster <italic>I</italic><sub>Ca</sub> inactivation of
 Ca<sub>V</sub>1.3<sub>42A</sub> was also seen at physiologically more relevant
 potentials, as indicated by a significant decrease in integrated
 <italic>I</italic><sub>Ca</sub> during 300-ms test pulses
 (<xref ref-type="fig" rid="fig3">Fig. 3<italic>c</italic></xref>). Note that
 voltage dependence of activation and inactivation is shifted by â¼15 mV to
 more positive voltages under our recording conditions
 (<xref ref-type="bibr" rid="ref5">5</xref>). Therefore, â20 mV
 corresponds to about â35 mV at physiological Ca<sup>2+</sup>
 concentrations.</p>
      <p>
        <fig position="float" id="fig3">
          <label>FIGURE 3.</label>
          <caption>
            <p><bold>Inactivation properties of Ca<sub>V</sub>1.3<sub>42</sub> and
 Ca<sub>V</sub>1.3<sub>42A</sub> channel-mediated currents.</bold> <italic>a,</italic>
 representative current traces of Ca<sub>V</sub>1.3<sub>42</sub>
 (<italic>black</italic>) and Ca<sub>V</sub>1.3<sub>42A</sub> (<italic>gray</italic>)
 <italic>I</italic><sub>Ca</sub> evoked by a 10-s depolarization to
 <italic>V</italic><sub>max</sub>. The <italic>inset</italic> illustrates inactivation during
 initial 30 ms. Cells: Ca<sub>V</sub>1.3<sub>42</sub>, 316h_51;
 Ca<sub>V</sub>1.3<sub>42A</sub>, 187g_46. <italic>b,</italic> percent
 <italic>I</italic><sub>Ca</sub> inactivation during 0.03-, 0.25-, 1-, and 5-s test
 pulses to <italic>V</italic><sub>max</sub>. ***, <italic>p</italic> â¤ 0.001, Student's
 <italic>t</italic> test. <italic>c,</italic> normalized representative <italic>I</italic><sub>Ca</sub>
 traces at physiologically relevant potentials (â20 mV; corresponding to
 â¼â35 mV at physiological Ca<sup>2+</sup> concentrations; see
 âResultsâ). Cells: Ca<sub>V</sub>1.3<sub>42</sub>, 196l_23;
 Ca<sub>V</sub>1.3<sub>42A</sub>, 187g_17. Integrated current corresponding to
 the area under normalized <italic>I</italic><sub>Ca</sub> during a 300-ms pulse is
 shown. Statistically significant difference: ***, <italic>p</italic> â¤ 0.001,
 Unpaired <italic>t</italic> test. <italic>d,</italic> percent <italic>I</italic><sub>Ba</sub>
 inactivation during 0.03-, 0.25-, 1-, and 5-s test pulses to
 <italic>V</italic><sub>max</sub>. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01,
 Student <italic>t</italic> test. <italic>e,</italic> voltage dependence of CDI for
 Ca<sub>V</sub>1.3<sub>42</sub> (<italic>left</italic>) and
 Ca<sub>V</sub>1.3<sub>42A</sub> (<italic>right</italic>): <italic>r</italic><sub>250</sub>
 corresponds to the fraction of <italic>I</italic><sub>Ca</sub> or
 <italic>I</italic><sub>Ba</sub> remaining after 250 ms; <italic>f</italic> is the difference
 between <italic>r</italic><sub>250</sub> values at +10 mV (for statistics see
 âResultsâ and <xref ref-type="table" rid="tbl3">Table
 3</xref>). Number of experiments is given in parentheses. <italic>Error
 bars</italic> reflect S.E.</p>
          </caption>
          <graphic xlink:href="zbc0310843690003"/>
        </fig>
      </p>
      <p>The faster inactivation of Ca<sub>V</sub>1.3<sub>42A</sub> could be due to
 faster voltage-dependent inactivation, faster CDI, or both. To address this
 question, we also quantified Ca<sub>V</sub>1.3-mediated
 <italic>I</italic><sub>Ba</sub> of both splice variants. Interestingly, mean
 <italic>I</italic><sub>Ba</sub> inactivation was even slower for
 Ca<sub>V</sub>1.3<sub>42A</sub> channels
 (<xref ref-type="fig" rid="fig3">Fig. 3<italic>d</italic></xref> and
 <xref ref-type="table" rid="tbl3">Table 3</xref>). This difference was
 because of a pronounced slowing of inactivation in 50% of the cells (%
 inactivation of Ca<sub>V</sub>1.3<sub>42A</sub> during 250 ms, 8.6 Â±
 1.2%, <italic>n</italic> = 7, in this subset). We have previously observed a similar
 slowing of inactivation of <italic>I</italic><sub>Ba</sub> in truncated
 Ca<sub>V</sub>1.4 channels
 (<xref ref-type="bibr" rid="ref15">15</xref>).</p>
      <p>From these data we conclude that the faster inactivation of
 <italic>I</italic><sub>Ca</sub> observed for Ca<sub>V</sub>1.3<sub>42A</sub> must be
 due to more pronounced CDI. As a quantitative measure of CDI, we analyzed the
 fraction of <italic>I</italic><sub>Ca</sub> through Ca<sub>V</sub>1.3 channels
 remaining after a 250-ms depolarization (<italic>r</italic><sub>250</sub>) in a wide
 voltage range (<xref ref-type="fig" rid="fig3">Fig.
 3<italic>e</italic></xref>). A typical U-shaped dependence on test voltage was
 observed for both splice variants, but it was more pronounced for
 Ca<sub>V</sub>1.3<sub>42A</sub> channels (<italic>f</italic> = 0.60 Â± 0.07
 <italic>versus</italic> 0.25 Â± 0.11 at 10 mV for Ca<sub>V</sub>1.3<sub>42</sub>
 channels). In agreement with a previous report
 (<xref ref-type="bibr" rid="ref13">13</xref>), Ca<sub>V</sub>1.3 CDI
 was CaM-mediated. <italic>I</italic><sub>Ca</sub> inactivation of
 Ca<sub>V</sub>1.3<sub>42A</sub> channels was dramatically slowed by
 co-expression of YFP-labeled dominant-negative CaM (CaM<sub>1234</sub>)
 (<italic>r</italic><sub>250</sub> at
 <italic>V</italic><sub>max</sub>:Ca<sub>V</sub>1.3<sub>42A</sub> + CaM<sub>1234</sub>,
 0.76 Â± 0.061%, <italic>n</italic> = 5, <italic>p</italic> &lt; 0.0001, Student's
 <italic>t</italic> test <italic>versus</italic> Ca<sub>V</sub>1.3<sub>42A</sub>) thus
 approaching <italic>r</italic><sub>250</sub> values for <italic>I</italic><sub>Ba</sub> (for
 comparison see <xref ref-type="fig" rid="fig3">Fig.
 3<italic>e</italic></xref>). CaM<sub>1234</sub> did not affect the
 hyperpolarizing shift of the <italic>I</italic><sub>Ca</sub> activation
 (<italic>V</italic><sub>0.5,act</sub>:Ca<sub>V</sub>1.3<sub>42A</sub> +
 CaM<sub>1234</sub>: â16.3 Â± 0.5 mV, <italic>n</italic> = 8) suggesting
 that the shift in activation voltage occurs independent of CaM as also shown
 previously for Ca<sub>V</sub>1.4
 (<xref ref-type="bibr" rid="ref15">15</xref>). Taken together, these
 data provide unequivocal evidence that the CTM in Ca<sub>V</sub>1.3 channels
 not only modulates its activity range but also moderates CDI.</p>
      <p><italic>Ca<sub>V</sub>1.3 CTM Lies within the Most Distal C-terminal Domain
 Highly Conserved in LTCCs</italic>âTo further strengthen this hypothesis and
 pinpoint important structural domains, we tested if different C-terminal
 truncations exhibit similar gating effects. In accordance to the C-terminal
 peptide C<sub>122</sub> important for Ca<sub>V</sub>1.4 channel modulation
 (<xref ref-type="bibr" rid="ref15">15</xref>), we deleted the
 corresponding distal 158 amino acids of Ca<sub>V</sub>1.3<sub>42</sub>. The
 resulting Ca<sub>V</sub>1.3<sub>ÎC158</sub> channels exhibited
 <italic>I</italic><sub>Ca</sub> and <italic>I</italic><sub>Ba</sub> activation properties
 comparable with Ca<sub>V</sub>1.3<sub>42A</sub> (Tables
 <xref ref-type="table" rid="tbl1">1</xref> and
 <xref ref-type="table" rid="tbl2">2</xref>). For
 <italic>I</italic><sub>Ca</sub>, <italic>k</italic><sub>act</sub> significantly decreased
 (Ca<sub>V</sub>1.3<sub>ÎC158</sub>: â7.4 Â± 0.2, <italic>n</italic>
 = 9; <italic>p</italic> &lt; 0.001; <xref ref-type="table" rid="tbl1">Table
 1</xref>), and <italic>V</italic><sub>0.5,act</sub>
 (Ca<sub>V</sub>1.3<sub>ÎC158</sub>: â14.3 Â± 0.4 mV,
 <italic>n</italic> = 9, <italic>p</italic> &lt; 0.001;
 <xref ref-type="table" rid="tbl1">Table 1</xref>) shifted to more
 hyperpolarized voltages. Like in Ca<sub>V</sub>1.3<sub>42A</sub>,
 <italic>I</italic><sub>Ca</sub> inactivation was faster, and CDI was more pronounced,
 and <italic>I</italic><sub>Ba</sub> was slowed (for all data and statistics see Tables
 <xref ref-type="table" rid="tbl1">1</xref>,
 <xref ref-type="table" rid="tbl2">2</xref>,
 <xref ref-type="table" rid="tbl3">3</xref>).</p>
      <p>To prove the modulatory role of the last 158 amino acid residues, we tested
 the capability of this C-terminal fragment to restore the gating changes
 induced by the truncation. Therefore, GFP-fused peptide (GFP-C<sub>158</sub>)
 was expressed together with the respective truncated channel.
 GFP-C<sub>158</sub> reverted the gating changes observed in
 Ca<sub>V</sub>1.3<sub>ÎC158</sub> channels to values similar to
 Ca<sub>V</sub>1.3<sub>42</sub>; the hyperpolarizing shift of the
 <italic>I</italic><sub>Ca</sub> activation curve was reversed
 (<italic>V</italic><sub>0.5,</sub>
 <sub>act</sub>:Ca<sub>V</sub>1.3<sub>ÎC158</sub> + GFP-C<sub>158</sub>,
 â0.8 Â± 1.4 mV <italic>n</italic> = 8, <italic>p</italic> = 0.3 <italic>versus</italic>
 Ca<sub>V</sub>1.3<sub>42</sub>; see <xref ref-type="table" rid="tbl1">Table
 1</xref>); <italic>I</italic><sub>Ca</sub> inactivation was slowed (during 30 ms:
 Ca<sub>V</sub>1.3<sub>ÎC158</sub> + GFP-C<sub>158</sub>; 23.5 Â±
 1.9%, <italic>n</italic> = 8, <italic>p</italic> = 0.2 <italic>versus</italic>
 Ca<sub>V</sub>1.3<sub>42</sub>; see <xref ref-type="table" rid="tbl3">Table
 3</xref>), and CDI was less pronounced as indicated by the decrease of
 the <italic>f</italic> value (at 10 mV, Ca<sub>V</sub>1.3<sub>ÎC158</sub> +
 GFP-C<sub>158</sub>, 0.2 Â± 0.08, <italic>n</italic> = 6â8; see
 <xref ref-type="table" rid="tbl3">Table 3</xref>). Peptide-induced
 reversal of activation and inactivation parameters was also observed in
 <italic>I</italic><sub>Ba</sub> (<xref ref-type="table" rid="tbl2">Table
 2</xref>).</p>
      <p>
        <fig position="float" id="fig4">
          <label>FIGURE 4.</label>
          <caption>
            <p><bold>Gating properties of Ca<sub>V</sub>1.3<sub>ÎC116</sub> channels
 and effect of the distal CTM peptide C<sub>116</sub>.</bold> Data for
 Ca<sub>V</sub>1.3<sub>42</sub> were taken from
 <xref ref-type="fig" rid="fig2">Fig. 2. <italic>a,</italic></xref>
 representative normalized <italic>I-V</italic> curves for <italic>I</italic><sub>Ca</sub>.
 Activation parameters were as follows (in mV): Ca<sub>V</sub>1.3<sub>42</sub>:
 <italic>V</italic><sub>0.5,act,</sub> â4.2, and <italic>k</italic><sub>act</sub>,
 â8.6; Ca<sub>V</sub>1.3<sub>ÎC116</sub>:
 <italic>V</italic><sub>0.5,act</sub>: â12.8, and <italic>k</italic><sub>act</sub>,
 â7.7; Ca<sub>V</sub>1.3<sub>ÎC116</sub>+GFP-C<sub>116</sub>:
 <italic>V</italic><sub>0.5,act</sub>, â4.7, and <italic>k</italic><sub>act</sub>,
 â8.8; Cells: 196l_23, 27g_57, and 27g_91, respectively. <italic>b,</italic>
 representative current traces of <italic>I</italic><sub>Ca</sub> evoked by a
 depolarization to <italic>V</italic><sub>max</sub>. Cells:
 Ca<sub>V</sub>1.3<sub>ÎC116</sub>, 27g_27;
 Ca<sub>V</sub>1.3<sub>ÎC116</sub>+GFP-C<sub>116</sub>, 197f_26.
 <italic>c,</italic> percent <italic>I</italic><sub>Ca</sub> inactivation during test pulses to
 <italic>V</italic><sub>max</sub>: **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt;
 0.001, compared with Ca<sub>V</sub>1.3<sub>42</sub> (<italic>black</italic>); +,
 <italic>p</italic> &lt; 0.05; +++, <italic>p</italic> &lt; 0.001, comparison of
 Ca<sub>V</sub>1.3<sub>ÎC116</sub> + GFP-C<sub>116</sub> (<italic>white</italic>)
 with Ca<sub>V</sub>1.3<sub>ÎC116</sub> (<italic>gray</italic>) alone (one-way
 ANOVA followed by Bonferroni post-test). Number of experiments is given in
 <italic>parentheses. Error bars</italic> reflect S.E. <italic>d</italic> and <italic>e,</italic>
 representative <italic>I</italic><sub>Ca</sub> traces for
 Ca<sub>V</sub>1.3<sub>ÎC116</sub> (<italic>d</italic>) and
 Ca<sub>V</sub>1.3<sub>ÎC116</sub>+GFP-C<sub>116</sub> (<italic>e</italic>).
 Cells: 27g_67 and 27g_91, respectively. For comparison to
 Ca<sub>V</sub>1.3<sub>42</sub> see <xref ref-type="fig" rid="fig2">Fig.
 2</xref>.</p>
          </caption>
          <graphic xlink:href="zbc0310843690004"/>
        </fig>
      </p>
      <p>To further restrict the protein domain important for CTM activity, we
 introduced additional truncations in the distal C terminus (Figs.
 <xref ref-type="fig" rid="fig4">4</xref>,
 <xref ref-type="fig" rid="fig5">5</xref>,
 <xref ref-type="fig" rid="fig6">6</xref>). Deletion of the last 76
 (Ca<sub>V</sub>1.3<sub>ÎC76</sub>) amino acids induced the same gating
 effects as described for Ca<sub>V</sub>1.3<sub>ÎC158</sub>. However,
 Ca<sub>V</sub>1.3<sub>ÎC76</sub> channel activity was not reverted to
 Ca<sub>V</sub>1.3<sub>42</sub>-like behavior by co-expression of peptide
 GFP-C<sub>76</sub> (for data and statistics see Tables
 <xref ref-type="table" rid="tbl1">1</xref>,
 <xref ref-type="table" rid="tbl2">2</xref>,
 <xref ref-type="table" rid="tbl3">3</xref>). This could not be explained
 by a lack of GFP-C<sub>76</sub> expression because full-length expression of
 this peptide was confirmed in Western blot experiments where the peptide
 expressed at comparable levels to GFP-C<sub>158</sub> (<italic>n</italic> = 3, not
 illustrated). Our data therefore suggest that the last 76 amino acids are
 required for the formation of CTM activity but cannot functionally recombine
 with its truncated counterpart to form a modulatory structure. Sequence
 alignment with other LTCCs (<xref ref-type="fig" rid="fig6">Fig.
 6</xref>) revealed that truncation ÎC76 cuts in half the most
 distal highly conserved domain. This may prevent recombination to a functional
 domain upon co-expression. Hence, we generated
 Ca<sub>V</sub>1.3<sub>ÎC116</sub> in which the conserved region was
 fully removed and subsequently co-expressed as a single peptide. As shown in
 <xref ref-type="fig" rid="fig4">Fig. 4</xref> and Tables
 <xref ref-type="table" rid="tbl1">1</xref>,
 <xref ref-type="table" rid="tbl2">2</xref>,
 <xref ref-type="table" rid="tbl3">3</xref>,
 Ca<sub>V</sub>1.3<sub>ÎC116</sub> again exhibited functional
 <italic>I</italic><sub>Ca</sub> and <italic>I</italic><sub>Ba</sub> properties similar to
 Ca<sub>V</sub>1.3<sub>42A</sub>. However, unlike in
 Ca<sub>V</sub>1.3<sub>ÎC76</sub>, the gating properties were reversed to
 those of Ca<sub>V</sub>1.3<sub>42</sub> after co-expression of the
 GFP-C<sub>116</sub> peptide (<xref ref-type="fig" rid="fig4">Fig.
 4</xref> and Tables <xref ref-type="table" rid="tbl1">1</xref>,
 <xref ref-type="table" rid="tbl2">2</xref>,
 <xref ref-type="table" rid="tbl3">3</xref>). Co-expression of the
 corresponding distal peptides not only reversed activation parameters and CDI
 but also significantly decreased mean <italic>I</italic><sub>Ca</sub> density by
 53â63% (<italic>p</italic> &lt; 0.05, <italic>n</italic> = 7â11). A similar trend
 was also seen for <italic>I</italic><sub>Ba</sub> (41â67%, <italic>n</italic> =
 7â11). These data implicate that Ca<sub>V</sub>1.3 Î±1 subunits
 contain critical structural elements required for CTM function within the last
 76 amino acids and that the last 116 residues perform CTM activity when
 co-expressed in HEK-293 cells.</p>
      <p><italic>Intramolecular Protein-Protein Interaction Regulates Ca<sub>V</sub>1.3
 Channel Gating</italic>âWe
 (<xref ref-type="bibr" rid="ref15">15</xref>) and others
 (<xref ref-type="bibr" rid="ref16">16</xref>) showed that in
 Ca<sub>V</sub>1.4 Î±1 subunits the distal CTM interacts with a more
 proximal domain containing the EF-hand, pre-IQ-, and IQ-motif. If such a
 mechanism also holds true for Ca<sub>V</sub>1.3 channels, CTM-containing
 peptides should also modulate Ca<sub>V</sub>1.3<sub>42A</sub> (containing
 EF-PreIQ-IQ). Interestingly, co-expression of GFP-C<sub>158</sub> neither
 reversed the Ca<sub>V</sub>1.3<sub>42A</sub>-induced hyperpolarizing shift of
 the activation range of <italic>I</italic><sub>Ca</sub>
 (Ca<sub>V</sub>1.3<sub>42A</sub> + GFP-C<sub>158</sub>:
 <italic>V</italic><sub>0.5,act</sub> = â12.6 Â± 1.5 mV, <italic>n</italic> = 7;
 <italic>p</italic> &lt; 0.001; see <xref ref-type="fig" rid="fig5">Fig.
 5<italic>a</italic></xref> and <xref ref-type="table" rid="tbl1">Table
 1</xref>) and <italic>I</italic><sub>Ba</sub>
 (<xref ref-type="table" rid="tbl2">Table 2</xref>) nor the
 voltage-dependent inactivation and CDI
 (<xref ref-type="fig" rid="fig5">Fig. 5, <italic>b</italic> and
 <italic>c</italic></xref>; <xref ref-type="table" rid="tbl3">Table
 3</xref>). This prompted us to extend the Ca<sub>V</sub>1.3 Î±1
 subunit C terminus to residue 1664 thereby including a highly conserved domain
 downstream of the IQ-motif that is missing in Ca<sub>V</sub>1.3<sub>42A</sub>
 and also contains the so-called PCRD domain previously identified as binding
 partner for C-terminal peptides in Ca<sub>V</sub>1.2 channels
 (<xref ref-type="fig" rid="fig6">Fig. 6</xref>)
 (<xref ref-type="bibr" rid="ref17">17</xref>). As expected, the
 resulting Ca<sub>V</sub>1.3<sub>ÎC473</sub> channels showed
 Ca<sub>V</sub>1.3<sub>42A</sub>-like gating (Tables
 <xref ref-type="table" rid="tbl1">1</xref>,
 <xref ref-type="table" rid="tbl2">2</xref>,
 <xref ref-type="table" rid="tbl3">3</xref>) but, in contrast to
 Ca<sub>V</sub>1.3<sub>42A</sub>, co-expression of GFP-C<sub>116</sub> restored
 CDI (<xref ref-type="fig" rid="fig5">Fig. 5, <italic>h</italic> and
 <italic>i</italic></xref>; <xref ref-type="table" rid="tbl3">Table
 3</xref>) and the activation and inactivation parameters for
 <italic>I</italic><sub>Ca</sub> (<xref ref-type="fig" rid="fig5">Fig. 5,
 <italic>dâf</italic> and <italic>h</italic> and <italic>i</italic></xref>; and Tables
 <xref ref-type="table" rid="tbl1">1</xref> and
 <xref ref-type="table" rid="tbl3">3</xref>) and <italic>I</italic><sub>Ba</sub>
 (Tables <xref ref-type="table" rid="tbl2">2</xref> and
 <xref ref-type="table" rid="tbl3">3</xref>) close to
 Ca<sub>V</sub>1.3<sub>42</sub> values. These data provide functional evidence
 for an important role of proximal residues 1626â1664 and the distal 116
 amino acids for CTM function.</p>
      <p>To provide further evidence for this mechanism, we measured FRET between
 different YFP-labeled C-terminal fragments and CFP-labeled C<sub>158</sub>
 (CFP-C<sub>158</sub>) as well as CFP-labeled C<sub>116</sub>
 (CFP-C<sub>116</sub>) (<xref ref-type="fig" rid="fig7">Fig. 7</xref>).
 The construct corresponding to the C-terminal fragment of
 Ca<sub>V</sub>1.3<sub>42A</sub> (YFP-EF-PreIQ-IQ) did not show significant
 FRET with the CFP-C<sub>158</sub> probe (legend to
 <xref ref-type="fig" rid="fig7">Fig. 7</xref>). By extending the
 Ca<sub>V</sub>1.3 YFP-EF-preIQ-IQ bait to residue 1664 yielding
 YFP-EF-preIQ-IQ-PCRD, a strong and significant FRET signal was measured with
 CFP-C<sub>158</sub> as well CFP-C<sub>116</sub>
 (<xref ref-type="fig" rid="fig7">Fig. 7</xref>), which is in excellent
 agreement with our electrophysiological data. Accordingly, no FRET was
 observed when CFP-C<sub>76</sub> peptide was used as a probe (not shown). For
 Ca<sub>V</sub>1.2 channels, interaction between a pair of arginine residues in
 the PCRD and a set of negatively charged residues in the distal C-terminal
 region (DCRD) was predicted (<xref ref-type="fig" rid="fig6">Fig.
 6</xref>) (<xref ref-type="bibr" rid="ref17">17</xref>). As shown
 in <xref ref-type="fig" rid="fig7">Fig. 7</xref>, mutating the two
 conserved arginines in the Ca<sub>V</sub>1.3 PCRD to glutamine
 (EF-preIQ-IQ-PCRD<italic><sup>RRQQ</sup></italic> containing R1640Q and R1641Q) still
 supported a significant FRET signal when co-expressed with
 CFP-C<sub>116</sub>. Using probe CFP-C<sub>116</sub><sup><italic>DEQQ</italic></sup>,
 where the two negative charges in DCRD conserved in Ca<sub>V</sub>1.3 were
 neutralized (D2073Q and E2076Q), significant FRET was eliminated for both
 EF-preIQ-IQ-PCRD and EF-preIQ-IQ-PCRD<italic><sup>RRQQ</sup></italic>. Therefore,
 neutralization of the two positive charges of the PCRD arginines is not
 sufficient to prevent the binding interaction suggesting that other binding
 determinants exist in the conserved domain between residues 1626 and 1664. Our
 data indicate an essential role of the two negative charges in the
 Ca<sub>V</sub>1.3<sub>42</sub> DCRD region, similar to Ca<sub>V</sub>1.2.</p>
      <p>
        <fig position="float" id="fig5">
          <label>FIGURE 5.</label>
          <caption>
            <p><bold>Ca<sub>V</sub>1.3<sub>ÎC473</sub> channel properties in absence
 and presence of distal CTM peptide C<sub>116</sub>.</bold> Data for
 Ca<sub>V</sub>1.3<sub>42</sub> (<italic>black</italic>) and
 Ca<sub>V</sub>1.3<sub>42A</sub> (<italic>gray</italic>) were taken from Figs.
 <xref ref-type="fig" rid="fig2">2</xref> and
 <xref ref-type="fig" rid="fig4">4</xref>. <italic>a,</italic> representative
 normalized <italic>I-V</italic> curves for <italic>I</italic><sub>Ca</sub>. Activation
 parameters (in mV): Ca<sub>V</sub>1.3<sub>42A</sub>:
 <italic>V</italic><sub>0.5,act</sub>, â14.3, and <italic>k</italic><sub>act</sub>,
 â6.8; Ca<sub>V</sub>1.3<sub>42A</sub> + GFP-C<sub>158</sub>:
 <italic>V</italic><sub>0.5,act</sub>, â13.5 and <italic>k</italic><sub>act</sub>,
 â7.2; Cells: 196l_32 and 217c_3, respectively. <italic>b,</italic>
 representative current traces of <italic>I</italic><sub>Ca</sub> evoked a 10-s
 depolarization to <italic>V</italic><sub>max</sub>. Cells:
 Ca<sub>V</sub>1.3<sub>42A</sub> + GFP-C<sub>158</sub>, 227k_19;
 Ca<sub>V</sub>1.3<sub>42</sub>, 316h_51; Ca<sub>V</sub>1.3<sub>42A</sub>,
 187g_46. <italic>c,</italic> percent <italic>I</italic><sub>Ca</sub> inactivation during test
 pulses to <italic>V</italic><sub>max</sub>:*, <italic>p</italic> &lt; 0.05; ***, <italic>p</italic>
 &lt; 0.001 compared with Ca<sub>V</sub>1.3<sub>42</sub>; ++, <italic>p</italic> &lt;
 0.01; +++, <italic>p</italic> &lt; 0.001, comparison of
 Ca<sub>V</sub>1.3<sub>42A</sub> + GFP-C<sub>158</sub> with
 Ca<sub>V</sub>1.3<sub>42A</sub> alone. <italic>d,</italic> representative normalized
 <italic>I-V</italic> curves for <italic>I</italic><sub>Ca</sub>. Activation parameters (in
 mV): Ca<sub>V</sub>1.3<sub>ÎC473</sub>: <italic>V</italic><sub>0.5,act</sub>,
 â14.4, and <italic>k</italic><sub>act</sub>, â7.1;
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> +GFP-C<sub>116</sub>:
 <italic>V</italic><sub>0.5,act</sub>, â2.4, and <italic>k</italic><sub>act</sub>,
 â9.4; Cells: 177i_1 and 167j_24, respectively. <italic>e,</italic> same
 conditions as in <italic>b.</italic> Cells: Ca<sub>V</sub>1.3<sub>ÎC473</sub>,
 247h_25; Ca<sub>V</sub>1.3<sub>ÎC473</sub> +GFP-C<sub>116</sub>,
 167j_14. <italic>f,</italic> percent <italic>I</italic><sub>Ca</sub> inactivation during test
 pulses to <italic>V</italic><sub>max</sub>:*, <italic>p</italic> &lt; 0.05; **, <italic>p</italic>
 &lt; 0.01; ***, <italic>p</italic> &lt; 0.001 compared with
 Ca<sub>V</sub>1.3<sub>42</sub>; +, <italic>p</italic> &lt; 0.05; ++, <italic>p</italic> &lt;
 0.01; +++, <italic>p</italic> &lt; 0.001, comparison of
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> + GFP-C<sub>116</sub> with
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> alone. <italic>gâi,</italic>
 representative <italic>I</italic><sub>Ca</sub> traces for
 Ca<sub>V</sub>1.3<sub>42A</sub> + GFP-C<sub>158</sub> (<italic>g</italic>),
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> (<italic>h</italic>), and
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> + GFP-C<sub>116</sub> (<italic>i</italic>)
 correspond to <italic>I-V</italic> curves in <italic>a</italic> and <italic>d</italic>. For comparison
 to Ca<sub>V</sub>1.3<sub>42</sub> and Ca<sub>V</sub>1.3<sub>42A</sub> see
 <xref ref-type="fig" rid="fig2">Fig. 2</xref>. For statistics: in
 <italic>a</italic> and <italic>d,</italic> Student's <italic>t</italic> test; <italic>c</italic> and
 <italic>f,</italic> one-way ANOVA followed by Bonferroni post-test. Number of
 experiments is given in <italic>parentheses. Error bars</italic> reflect S.E.</p>
          </caption>
          <graphic xlink:href="zbc0310843690005"/>
        </fig>
      </p>
      <p>To address the question if the moderation of CDI by the CTM involves
 modulation of CaM interaction with its C-terminal interaction domains, we
 measured if the presence of the CTM can affect the constitutive binding of CaM
 at resting intracellular Ca<sup>2+</sup> concentrations. We measured FRET
 between CFP-labeled calmodulin (CFP-CaM) and the fragments YFP-EF-preIQ-IQ
 (mimicking the short Ca<sub>V</sub>1.3<sub>42A</sub>), YFP-EF-preIQ-IQ-PCRD,
 and a peptide corresponding to the complete Ca<sub>V</sub>1.3 C terminus
 (YFP-Ca<sub>V</sub>1.3-C terminus), including the CTM (corresponding to the
 long Ca<sub>V</sub>1.3<sub>42</sub>). Whereas significant
 <italic>N</italic><sub>FRET</sub> (<italic>p</italic> &lt; 0.001 <italic>versus</italic>
 YFP-Ca<sub>V</sub>1.3-C terminus; one-way ANOVA, Bonferroni post-test) was
 measured for YFP-EF-preIQ-IQ (0.185 Â± 0.009, <italic>n</italic> = 12) and
 YFP-EF-preIQ-IQ-PCRD (0.235 Â± 0.007, <italic>n</italic> = 3), no significant
 <italic>N</italic><sub>FRET</sub> was obtained for YFP-Ca<sub>V</sub>1.3-C terminus
 (0.039 Â± 0.017, <italic>n</italic> = 6, <italic>p</italic> = 0.07. one-sample
 <italic>t</italic> test, compared with 0). This is in excellent agreement with our
 previous findings in Ca<sub>V</sub>1.4 channels
 (<xref ref-type="bibr" rid="ref15">15</xref>) indicating that the
 Ca<sub>V</sub>1.3 CTM interferes with CaM coordination to the C terminus in
 intact cells. This also provides a plausible mechanism for explaining the
 moderation of CDI.</p>
      <p>We also investigated whether the function of the CTM was prevented by
 alternative splicing of exon 44 in the post-IQ region of the C terminus
 (<xref ref-type="fig" rid="fig6">Fig. 6</xref>). Introduction of 9
 amino acid corresponding to exon 44 into a full-length Ca<sub>V</sub>1.3
 construct (Ca<sub>V</sub>1.3<sub>42+44</sub>) exhibited activation parameters
 similar to Ca<sub>V</sub>1.3<sub>42</sub> (<italic>I</italic><sub>Ba</sub>:
 <italic>V</italic><sub>0.5,</sub> <sub>act</sub> = â14.8 Â± 1.2 mV,
 <italic>k</italic><sub>act</sub> = â9.3 Â± 0.3 mV, <italic>n</italic> = 14;
 <italic>I</italic><sub>Ca</sub>, <italic>V</italic><sub>0.5,</sub> <sub>act</sub> = â3.7
 Â± 1.02 mV, <italic>k</italic><sub>act</sub> = â10.6 Â± 0.3 mV,
 <italic>n</italic> = 8) suggesting that CTM function was not prevented by alternative
 splicing of this exon.</p>
      <p><italic>Ca<sub>V</sub>1.3<sub>42</sub> and Ca<sub>V</sub>1.3<sub>42A</sub> Are
 Both Expressed in Mouse and Human Tissues</italic>âWe employed PCR to
 determine whether both long (CTM-containing) and short (CTM-deficient) splice
 variants are expressed in mouse and human tissue. RT-PCR experiments
 identified both exon 42 and 42A mRNA in different mouse brain regions and the
 organ of Corti (<xref ref-type="fig" rid="fig8">Fig.
 8<italic>a</italic></xref>) as well as in human brain, heart, retina, and
 pancreas (<xref ref-type="fig" rid="fig8">Fig. 8<italic>b</italic></xref>).
 Using quantitative real time PCR, we determined the relative abundance of
 these transcripts in mouse whole-brain as well as several brain sub-regions
 (<xref ref-type="fig" rid="fig8">Fig. 8<italic>c</italic></xref>). Because
 exons 42 and 42A are used in a mutually exclusive manner, we calculated the
 relative amount of exon 42A as percentage of the sum of exon 42 and 42A
 containing mRNA molecules in samples from two to three independent RNA
 preparations. Although exon 42 was the predominant form in whole-brain and all
 sub-regions investigated, significant expression of exon 42A was also found.
 In whole-brain preparations, exon 42A was 11.0 Â± 0.6% (<italic>n</italic> = 8)
 of the two mRNAs. Variable expression was found in brain sub-regions with the
 highest expression in cerebellum (17.1 Â± 2.5%, <italic>n</italic> = 4) and the
 nucleus accumbens (13.3 Â± 1.5%, <italic>n</italic> = 3) and the lowest in
 olfactory bulb (2.1 Â± 0.2%, <italic>n</italic> = 3). These data suggest that
 the short Ca<sub>V</sub>1.3 splice variant can contribute significantly to
 overall Ca<sub>V</sub>1.3 activity. Notably, our experiments do not rule out
 the possibility of other short isoforms with gating properties similar to
 Ca<sub>V</sub>1.3<sub>42A</sub>. Therefore the contribution of short forms to
 overall Ca<sub>V</sub>1.3 expression is likely to be underestimated by our
 experiments.</p>
      <p>
        <fig position="float" id="fig6">
          <label>FIGURE 6.</label>
          <caption>
            <p><bold>Sequence alignment of LTCC C termini.</bold> A sequence alignment of
 neuronal human Ca<sub>V</sub>1.3 (GenBankâ¢ accession number NM_000720),
 Ca<sub>V</sub>1.4 (GenBankâ¢ accession number AJ224874), and
 Ca<sub>V</sub>1.2 (uniprot accession number Q13936) Î±1 subunits is
 shown. Sequence identity (<italic>dark gray</italic>), similarity (<italic>light
 gray</italic>) and gaps (â) are indicated. <italic>PCRD</italic>, proximal
 C-terminal regulatory domain; <italic>DCRD</italic>, distal C-terminal regulatory
 domain; CTM, <italic>dotted line</italic>. Position of Ca<sub>V</sub>1.3<sub>42A</sub>
 and truncation mutants Ca<sub>V</sub>1.3<sub>ÎC473</sub>,
 Ca<sub>V</sub>1.3<sub>ÎC158,</sub>
 Ca<sub>V</sub>1.3<sub>ÎC116</sub>, and
 Ca<sub>V</sub>1.3<sub>ÎC76</sub> are indicated by <italic>black arrows.</italic>
 Position of exon 44 is given.</p>
          </caption>
          <graphic xlink:href="zbc0310843690006"/>
        </fig>
      </p>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>Here we present functional evidence for a C-terminal automodulatory domain
 that controls voltage- and Ca<sup>2+</sup>-dependent gating properties of
 Ca<sub>V</sub>1.3 LTCCs. Such modulation has not been described for
 Ca<sub>V</sub>1.3 channels before. The absence of the CTM in the short splice
 variant Ca<sub>V</sub>1.3<sub>42A</sub> provides functional diversity to
 Ca<sub>V</sub>1.3 channels. Ca<sub>V</sub>1.3<sub>42A</sub> mRNA is expressed
 together with Ca<sub>V</sub>1.3<sub>42</sub> in different mouse and human
 tissues suggesting that this functional diversity is of physiological
 relevance to adapt Ca<sub>V</sub>1.3 channel activity for specific
 physiological needs. Activation at negative voltages is one hallmark of
 Ca<sub>V</sub>1.3 channels (for review see Ref.
 <xref ref-type="bibr" rid="ref6">6</xref>) crucial for adequate
 neurotransmitter release in IHCs and pacemaker function in the SAN,
 atrioventricular conduction
 (<xref ref-type="bibr" rid="ref30">30</xref>,
 <xref ref-type="bibr" rid="ref31">31</xref>), and neuronal excitability
 (<xref ref-type="bibr" rid="ref7">7</xref>,
 <xref ref-type="bibr" rid="ref32">32</xref>). In the absence of the
 CTM, <italic>V</italic><sub>0.5,act</sub> is shifted about 10 mV to more negative
 voltages by decreasing the slope factor of the activation curve but without
 measurable effects on the activation threshold. This effect was not correlated
 with current densities, was independent from cell passage number, and was
 reproducibly observed for splice variant Ca<sub>V</sub>1.3<sub>42A</sub> as
 well as for several truncations mutants. Moreover, it could not be attributed
 to artificial manipulations of the Ca<sub>V</sub>1.3Î±1 subunits because
 it was observed in wild-type channel constructs not modified by fusion to GFP
 or introduction of other tags. In addition, co-expression of peptides
 containing the CTM with truncation mutants
 Ca<sub>V</sub>1.3<sub>ÎC116</sub>,
 Ca<sub>V</sub>1.3<sub>ÎC158</sub>, and
 Ca<sub>V</sub>1.3<sub>ÎC473</sub> reversed this shift. Cells may
 therefore adjust the activity of Ca<sub>V</sub>1.3-mediated signaling by
 varying the relative abundance of CTM-containing splice variants.</p>
      <p>
        <fig position="float" id="fig7">
          <label>FIGURE 7.</label>
          <caption>
            <p><bold>FRET analysis of the binding of peptide C<sub>158</sub> or
 C<sub>116</sub> to various fragments of the Ca<sub>V</sub>1.3 C terminus.</bold>
 <italic>N</italic><sub>FRET</sub> values obtained from co-expression of
 CFP-C<sub>158</sub> or CFP-C<sub>116</sub> (<italic>probe</italic>) with the indicated
 YFP-tagged Ca<sub>V</sub>1.3 C-terminal fragments in HEK-293 cells. All
 constructs showed a homogeneous intracellular distribution. As controls,
 <italic>N</italic><sub>FRET</sub> values are given for CFP co-expressed with
 YFP-EF-PreIQ-IQ-PCRD (<italic>CFP control</italic>) and YFP with probes
 CFP-C<sub>158</sub> (<italic>YFP control 1</italic>) and CFP-C<sub>116</sub> (<italic>YFP
 control 2</italic>). Controls are not significantly different from zero
 (one-sample <italic>t</italic> test against 0). Interaction between fragments was
 considered when significant difference to both the CFP- and the corresponding
 YFP control was observed (***, <italic>p</italic> &lt; 0.001, one-way ANOVA followed
 by Bonferroni post-test).</p>
          </caption>
          <graphic xlink:href="zbc0310843690007"/>
        </fig>
      </p>
      <p>
        <fig position="float" id="fig8">
          <label>FIGURE 8.</label>
          <caption>
            <p><bold>Tissue expression of Ca<sub>V</sub>1.3 C-terminal splice variants.</bold>
 Qualitative RT-PCR experiments showing expression of both long (containing
 exon (<italic>Ex</italic>) 42) and short (containing exon 42A) Ca<sub>V</sub>1.3
 isoforms in different mouse (<italic>a</italic>) and human (<italic>b</italic>) tissues. GAPDH
 was used as a housekeeping gene. One representative out of at least three
 independent experiments is shown. Quantitative Taqman RT-PCR experiments in
 <italic>a</italic> (<italic>right</italic>), show the relative expression of exons 42 and 42A
 in percent of total signal in mouse whole-brain and several brain subregions
 (***, <italic>p</italic> &lt; 0.001, unpaired Students <italic>t</italic> test, all
 significantly different from 0, one sample <italic>t</italic> test). Data are given as
 means Â± S.E.</p>
          </caption>
          <graphic xlink:href="zbc0310843690008"/>
        </fig>
      </p>
      <p>The functional properties of Ca<sub>V</sub>1.3<sub>42</sub> and
 Ca<sub>V</sub>1.3<sub>42A</sub> channels have been studied in previous
 reports. In two studies functional differences were observed between these
 splice variants, termed Ca<sub>V</sub>1.3a and Ca<sub>V</sub>1.3b therein,
 respectively. Calin-Jageman <italic>et al</italic>.
 (<xref ref-type="bibr" rid="ref39">39</xref>) found that VDF of rat
 Ca<sub>V</sub>1.3 channels expressed in HEK-293T cells was significantly more
 pronounced for Ca<sub>V</sub>1.3<sub>42A</sub> than for
 Ca<sub>V</sub>1.3<sub>42</sub> suggesting an autoinhibitory effect of the
 C-terminal tail on VDF. Comparisons of <italic>I-V</italic> relationship and
 <italic>I</italic><sub>Ca</sub> were not reported in this study. Zhang <italic>et al.</italic>
 (<xref ref-type="bibr" rid="ref37">37</xref>) expressed
 hemagglutinin-tagged splice variants in <italic>Xenopus laevis</italic> oocytes and
 found that <italic>I</italic><sub>Ba</sub> of the Ca<sub>V</sub>1.3<sub>42A</sub>
 construct was not only larger in amplitude but also its <italic>I-V</italic>
 relationship was shifted toward more negative voltages, similar to our
 findings. <italic>I</italic><sub>Ca</sub> was not reported. Although a more detailed
 comparison of the biophysical properties of Ca<sub>V</sub>1.3<sub>42</sub> and
 Ca<sub>V</sub>1.3<sub>42A</sub> was not the purpose of these studies, they
 support a modulatory role of the C terminus. In contrast, other groups using
 the corresponding (<xref ref-type="bibr" rid="ref5">5</xref>,
 <xref ref-type="bibr" rid="ref13">13</xref>) or different
 (<xref ref-type="bibr" rid="ref33">33</xref>) rat
 Ca<sub>V</sub>1.3<sub>42</sub> and Ca<sub>V</sub>1.3<sub>42A</sub> Î±1
 subunit analogues found neither major differences in the activation voltage
 range nor in CDI (<xref ref-type="bibr" rid="ref13">13</xref>).
 Therefore, <italic>V</italic><sub>0.5,act</sub> and <italic>V</italic><sub>max</sub> values
 for <italic>I</italic><sub>Ba</sub> as well as the extent of CDI closely resemble our
 human Ca<sub>V</sub>1.3<sub>42A</sub> channels
 (<xref ref-type="bibr" rid="ref5">5</xref>,
 <xref ref-type="bibr" rid="ref13">13</xref>,
 <xref ref-type="bibr" rid="ref12">12</xref>). Even though at present
 the molecular basis for this difference is unclear, chimeric constructs
 between rat and human Ca<sub>V</sub>1.3 constructs expressed under identical
 experimental conditions (<italic>e.g.</italic> to exclude confounding effects of the
 heterologous expression system and/or accessory subunit composition) will help
 to clarify this question.</p>
      <p>Our observation of a modulatory C-terminal domain in Ca<sub>V</sub>1.3 adds
 to recent discoveries of a similar regulatory principle in other LTCC isoforms
 (see Refs. <xref ref-type="bibr" rid="ref15">15</xref>,
 <xref ref-type="bibr" rid="ref17">17</xref>, and references therein).
 Autoinhibitory control of Ca<sub>V</sub>1.2 channel function was proposed to
 be based on a binding interaction between a pair of exposed arginine residues
 and negatively charged residues in Î±-helical motifs in a proximal (PCRD)
 and a distal (DCRD) conserved region of the C terminus, respectively
 (<xref ref-type="bibr" rid="ref17">17</xref>). In our human
 Ca<sub>V</sub>1.3 channels, 39 residues (1626â1664) comprising the
 proximal conserved domain containing the PCRD were necessary to confer
 modulation, as well as FRET to co-expressed CTM-containing peptides.
 Neutralization of the two conserved positive charges in PCRD did not prevent
 FRET implying other essential motifs within this 39-residue PCRD domain.
 Evidence for a role of DCRD comes from the finding that two conserved negative
 charges are required to support binding of CFP-C<sub>116</sub> to the upstream
 domain.</p>
      <p>The functional consequences of LTCC C-terminal modulation appear different
 in Ca<sub>V</sub>1.2 and Ca<sub>V</sub>1.3 channels. In Ca<sub>V</sub>1.2,
 C-terminal truncation does not induce a more negative
 <italic>V</italic><sub>0.5,act</sub>, but overexpression of the distal C terminus
 shifts the activation range to more positive voltages and reduces the coupling
 efficiency of voltage-sensing to channel opening
 (<xref ref-type="bibr" rid="ref17">17</xref>). This is in contrast to
 Ca<sub>V</sub>1.4 and Ca<sub>V</sub>1.3 channels in which removal of the CTM
 facilitates activation within a more negative voltage range and CTM
 co-expression restores gating
 (<xref ref-type="bibr" rid="ref15">15</xref> and this paper).
 Differences between LTCCs also exist with respect to the moderation of CDI.
 Although in both channels the CTM is able to interfere with CaM association,
 the CTM completely prevents CDI in Ca<sub>V</sub>1.4
 (<xref ref-type="bibr" rid="ref15">15</xref>) but only moderates CDI in
 Ca<sub>V</sub>1.3. To our knowledge the effects of the C-terminal
 autoinhibitory domain on CDI of Ca<sub>V</sub>1.2 channels has not been
 systematically analyzed so far.</p>
      <p>Our finding of C-terminal modulation of Ca<sub>V</sub>1.3 also raises the
 important question about potential post-translational proteolytic cleavage in
 the long C terminus. Such has been reported for Ca<sub>V</sub>1.1 and
 Ca<sub>V</sub>1.2 channels
 (<xref ref-type="bibr" rid="ref18">18</xref>,
 <xref ref-type="bibr" rid="ref34">34</xref>). The Ca<sub>V</sub>1.2
 cleavage product not only serves as a potent autoinhibitor when it remains
 noncovalently bound to the channel
 (<xref ref-type="bibr" rid="ref17">17</xref>) but may also dissociate
 from the Î±1 subunit thereby serving as a transcriptional regulator after
 translocation to the nucleus
 (<xref ref-type="bibr" rid="ref19">19</xref>). So far biochemical
 evidence for Ca<sub>V</sub>1.3 C-terminal cleavage is lacking, and it does not
 appear to function as a transcriptional regulator
 (<xref ref-type="bibr" rid="ref19">19</xref>). Instead, as demonstrated
 here, alternative splicing can generate short and functionally distinct
 Ca<sub>V</sub>1.3 variants. Such splicing has not yet been reported for
 Ca<sub>V</sub>1.1, Ca<sub>V</sub>1.2, or Ca<sub>V</sub>1.4 channels.</p>
      <p>Our data predict that the expression of Ca<sub>V</sub>1.3<sub>42A</sub>
 would allow a cell to promote Ca<sup>2+</sup> entry through Ca<sub>V</sub>1.3
 channels at sub-threshold voltages as predicted from the negative shift of the
 window current (<xref ref-type="fig" rid="fig2">Fig.
 2<italic>e</italic></xref>). Stronger activation at more negative voltages may
 also facilitate the onset of upstate potentials in neurons. However, during
 maintained depolarization, the faster CDI would limit Ca<sup>2+</sup> entry
 through these channels as relevant in neurons with Ca<sub>V</sub>1.3-dependent
 pacemaking, <italic>e.g.</italic> dopamine-containing neurons in the substantia nigra
 (<xref ref-type="bibr" rid="ref36">36</xref>). Whereas negative
 activation of an even small Ca<sub>V</sub>1.3 current could trigger
 pacemaking, faster CDI would limit Ca<sup>2+</sup> entry during ensuing action
 potentials. This may be important in these neurons that are susceptible to
 Ca<sup>2+</sup> toxicity and neuro-degeneration in Parkinson disease
 (<xref ref-type="bibr" rid="ref36">36</xref>). In contrast, the CTM in
 Ca<sub>V</sub>1.3<sub>42</sub> channels may be required for longer lasting
 Ca<sup>2+</sup> signals triggered by stronger depolarization inducing
 cAMP-response element-binding protein phosphorylation and synaptic plasticity
 (<xref ref-type="bibr" rid="ref37">37</xref>).</p>
      <p>Our study raises several important questions that need to be addressed in
 future studies. The fact that the increase in current density observed in
 Ca<sub>V</sub>1.3<sub>42A</sub> channels seems not to be due to increased
 expression density (and increased gating currents, see
 <xref ref-type="fig" rid="fig2">Fig. 2</xref>) suggests differences in
 the unitary current (<italic>e.g.</italic> increase in single-channel conductance or
 open probability or prolonged open times). Single-channel analysis will also
 be required to provide a mechanistic explanation for the shift in activation
 gating parameters in the short Ca<sub>V</sub>1.3 channels. Changes in the
 unitary conductance of Ca<sub>V</sub>1.2 channels induced by structural
 alterations within the CaM interaction domains in the C terminus well outside
 the known pore-forming regions have been described
 (<xref ref-type="bibr" rid="ref38">38</xref>) providing evidence for a
 conformational link of the CaM binding domain not only with the gating
 machinery but also with the channel pore.</p>
      <p>Several proteins binding to interaction domains of the C terminus have been
 described. For example, in neurons the multifunctional PDZ protein Erbin binds
 to a PDZ-binding domain formed by the last four amino acid residues of
 Ca<sub>V</sub>1.3<sub>42</sub> and thereby relieves the autoinhibitory effect
 of the C terminus on VDF (see Ref.
 <xref ref-type="bibr" rid="ref39">39</xref> and see above). Also Shank
 protein (<xref ref-type="bibr" rid="ref40">40</xref>) and RIM-binding
 protein (<xref ref-type="bibr" rid="ref41">41</xref>) are predicted to
 bind selectively to the C terminus of Ca<sub>V</sub>1.3 channels and may
 therefore affect CTM function. The fact that the distal C terminus comprising
 the CTM also contains regulatory sites, including sites for cAMP-dependent
 protein kinase phosphorylation
 (<xref ref-type="bibr" rid="ref42">42</xref>) and AKAP-15
 (<xref ref-type="bibr" rid="ref43">43</xref>), raises the interesting
 possibility that their interference with the activity of the CTM itself could
 also serve as mechanism to fine-tune Ca<sub>V</sub>1.3 function. Such a
 mechanism has recently been proposed to explain the still enigmatic mechanism
 of cAMP-dependent protein kinase-dependent activation of Ca<sub>V</sub>1.2
 LTCCs (<xref ref-type="bibr" rid="ref35">35</xref>).</p>
      <p>Taken together, we have identified a modulatory domain in Ca<sub>V</sub>1.3
 LTCCs responsible for profound differences in the Ca<sup>2+</sup>- and
 voltage-dependent gating of the different C-terminal splice variants. Given
 that many unique physiological functions of Ca<sub>V</sub>1.3 depend on the
 negative activation range of the channel and the amount of Ca<sup>2+</sup>
 ions entering during plateau
 (<xref ref-type="bibr" rid="ref7">7</xref>) or single action potentials
 (<xref ref-type="bibr" rid="ref8">8</xref>), our findings identify the
 CTM and factors that modify its activity (such as alternative splicing) as
 elements suitable to determine electrical excitability. Future experiments
 must also address the interesting possibility that interference with this
 C-terminal regulatory mechanism can also be exploited for pharmacological
 intervention, as an alternative to classical Ca<sup>2+</sup> channel
 modulators.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Dr. Simone Sartori for the preparation of mouse brain subregions.
 We thank Ursula Einzinger, Perrine Busquet, and Gilda Pelster for help with
 quantitative RT-PCRs. We also thank Sylvia Kaperek for preparation of cDNA
 from the mouse organ of Corti, Gilda Pelster and Irene Frischauf, Heike Kahr,
 and Sabine Buchegger for excellent technical assistance.</p>
    </ack>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation publication-type="journal">Catterall, W. A., Perez-Reyes, E., Snutch, T. P., and Striessnig,
 J. (<year>2005</year>) <source>Pharmacol. Rev.</source>
 <volume>57</volume>
 <fpage>411</fpage>â425<pub-id pub-id-type="pmid">16382099</pub-id></mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation publication-type="journal">Striessnig, J. (<year>2007</year>) <source>J. Physiol.
 (Lond.)</source> <volume>585</volume>
 <fpage>643</fpage>â644<pub-id pub-id-type="pmid">18084049</pub-id></mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation publication-type="journal">Platzer, J., Engel, J., Schrott-Fischer, A., Stephan, K., Bova, S.,
 Chen, H., Zheng, H., and Striessnig, J. (<year>2000</year>)
 <source>Cell</source> <volume>102</volume>
 <fpage>89</fpage>â97<pub-id pub-id-type="pmid">10929716</pub-id></mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation publication-type="journal">Koschak, A., Reimer, D., Huber, I., Grabner, M., Glossmann, H.,
 Engel, J., and Striessnig, J. (<year>2001</year>) <source>J. Biol.
 Chem.</source> <volume>276</volume>
 <fpage>22100</fpage>â22106<pub-id pub-id-type="pmid">11285265</pub-id></mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation publication-type="journal">Xu, W., and Lipscombe, D. (<year>2001</year>) <source>J.
 Neurosci.</source> <volume>21</volume>
 <fpage>5944</fpage>â5951<pub-id pub-id-type="pmid">11487617</pub-id></mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation publication-type="journal">Lipscombe, D., Helton, T. D., and Xu, W. (<year>2004</year>)
 <source>J. Neurophysiol.</source> <volume>92</volume>
 <fpage>2633</fpage>â2641<pub-id pub-id-type="pmid">15486420</pub-id></mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation publication-type="journal">Olson, P. A., Tkatch, T., Hernandez-Lopez, S., Ulrich, S., Ilijic,
 E., Mugnaini, E., Zhang, H., Bezprozvanny, I., and Surmeier, D. J.
 (<year>2005</year>) <source>J. Neurosci.</source>
 <volume>25</volume>
 <fpage>1050</fpage>â1062<pub-id pub-id-type="pmid">15689540</pub-id></mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation publication-type="journal">Helton, T. D., Xu, W., and Lipscombe, D. (<year>2005</year>)
 <source>J. Neurosci.</source> <volume>25</volume>
 <fpage>10247</fpage>â10251<pub-id pub-id-type="pmid">16267232</pub-id></mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation publication-type="other">Halling, D. B., Aracena-Parks, P., and Hamilton, S. L.
 (<year>2006</year>) <source>Sci. STKE 2006</source>,
 <fpage>er1</fpage></mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation publication-type="journal">Liang, H., DeMaria, C. D., Erickson, M. G., Mori, M. X., Alseikhan,
 B. A., and Yue, D. T. (<year>2003</year>) <source>Neuron</source>
 <volume>39</volume>
 <fpage>951</fpage>â960<pub-id pub-id-type="pmid">12971895</pub-id></mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <mixed-citation publication-type="journal">Soldatov, N. M., Zuhlke, R. D., Bouron, A., and Reuter, H.
 (<year>1997</year>) <source>J. Biol. Chem.</source>
 <volume>272</volume>
 <fpage>3560</fpage>â3566<pub-id pub-id-type="pmid">9013606</pub-id></mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <mixed-citation publication-type="journal">Shen, Y., Yu, D., Hiel, H., Liao, P., Yue, D. T., Fuchs, P. A., and
 Soong, T. W. (<year>2006</year>) <source>J. Neurosci.</source>
 <volume>26</volume>
 <fpage>10690</fpage>â10699<pub-id pub-id-type="pmid">17050708</pub-id></mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <mixed-citation publication-type="journal">Yang, P. S., Alseikhan, B. A., Hiel, H., Grant, L., Mori, M. X.,
 Yang, W., Fuchs, P. A., and Yue, D. T. (<year>2006</year>) <source>J.
 Neurosci.</source> <volume>26</volume>
 <fpage>10677</fpage>â10689<pub-id pub-id-type="pmid">17050707</pub-id></mixed-citation>
      </ref>
      <ref id="d31e6199">
        <label>14</label>
        <mixed-citation publication-type="journal">Cui, G., Meyer, A. C., Calin-Jageman, I., Neef, J., Haeseleer, F.,
 Moser, T., and Lee, A. (<year>2007</year>) <source>J. Physiol.
 (Lond.)</source> <volume>585</volume>
 <fpage>791</fpage>â803<pub-id pub-id-type="pmid">17947313</pub-id></mixed-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <mixed-citation publication-type="journal">Singh, A., Hamedinger, D., Hoda, J. C., Gebhart, M., Koschak, A.,
 Romanin, C., and Striessnig, J. (<year>2006</year>) <source>Nat.
 Neurosci.</source> <volume>9</volume>
 <fpage>1108</fpage>â1116<pub-id pub-id-type="pmid">16921373</pub-id></mixed-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <mixed-citation publication-type="journal">Wahl-Schott, C., Baumann, L., Cuny, H., Eckert, C., Griessmeier,
 K., and Biel, M. (<year>2006</year>) <source>Proc. Natl. Acad. Sci. U. S.
 A.</source> <volume>103</volume>
 <fpage>15657</fpage>â15662<pub-id pub-id-type="pmid">17028172</pub-id></mixed-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <mixed-citation publication-type="journal">Hulme, J. T., Yarov-Yarovoy, V., Lin, T. W., Scheuer, T., and
 Catterall, W. A. (<year>2006</year>) <source>J. Physiol.
 (Lond.)</source> <volume>576</volume>
 <fpage>87</fpage>â102<pub-id pub-id-type="pmid">16809371</pub-id></mixed-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <mixed-citation publication-type="journal">Hulme, J. T., Konoki, K., Lin, T. W., Gritsenko, M. A., Camp, D.
 G., II, Bigelow, D. J., and Catterall, W. A. (<year>2005</year>)
 <source>Proc. Natl. Acad. Sci. U. S. A.</source>
 <volume>102</volume>
 <fpage>5274</fpage>â5279<pub-id pub-id-type="pmid">15793008</pub-id></mixed-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <mixed-citation publication-type="journal">Gomez-Ospina, N., Tsuruta, F., Barreto-Chang, O., Hu, L., and
 Dolmetsch, R. (<year>2006</year>) <source>Cell</source>
 <volume>127</volume>
 <fpage>591</fpage>â606<pub-id pub-id-type="pmid">17081980</pub-id></mixed-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <mixed-citation publication-type="journal">Ganesan, A. N., Maack, C., Johns, D. C., Sidor, A., and O'Rourke,
 B. (<year>2006</year>) <source>Circ. Res.</source>
 <volume>98</volume> <fpage>e11</fpage>-8<pub-id pub-id-type="pmid">16397147</pub-id></mixed-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <mixed-citation publication-type="journal">Gao, T., Cuadra, A. E., Ma, H., Bunemann, M., Gerhardstein, B. L.,
 Cheng, T., Eick, R. T., and Hosey, M. M. (<year>2001</year>) <source>J.
 Biol. Chem.</source> <volume>276</volume>
 <fpage>21089</fpage>â21097<pub-id pub-id-type="pmid">11274161</pub-id></mixed-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <mixed-citation publication-type="journal">Grabner, M., Dirksen, R. T., and Beam, K. G. (<year>1998</year>)
 <source>Proc. Natl. Acad. Sci. U. S. A.</source>
 <volume>95</volume>
 <fpage>1903</fpage>â1908<pub-id pub-id-type="pmid">9465115</pub-id></mixed-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <mixed-citation publication-type="journal">Michna, M., Knirsch, M., Hoda, J. C., Muenkner, S., Langer, P.,
 Platzer, J., Striessnig, J., and Engel, J. (<year>2003</year>) <source>J.
 Physiol. (Lond.)</source> <volume>553</volume>
 <fpage>747</fpage>â758<pub-id pub-id-type="pmid">14514878</pub-id></mixed-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <mixed-citation publication-type="journal">Koschak, A., Obermair, G. J., Pivotto, F., Sinnegger-Brauns, M. J.,
 Striessnig, J., and Pietrobon, D. (<year>2007</year>) <source>J.
 Neurosci.</source> <volume>27</volume>
 <fpage>3855</fpage>â3863<pub-id pub-id-type="pmid">17409250</pub-id></mixed-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <mixed-citation publication-type="journal">Huber, I., Wappl, E., Herzog, A., Mitterdorfer, J., Glossmann, H.,
 Langer, T., and Striessnig, J. (<year>2000</year>) <source>Biochem.
 J.</source> <volume>347</volume>
 <fpage>829</fpage>â836<pub-id pub-id-type="pmid">10769189</pub-id></mixed-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <mixed-citation publication-type="journal">Xia, Z., and Liu, Y. (<year>2001</year>) <source>Biophys.
 J.</source> <volume>81</volume>
 <fpage>2395</fpage>â2402<pub-id pub-id-type="pmid">11566809</pub-id></mixed-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <mixed-citation publication-type="journal">Hui, A., Ellinor, P. T., Krizanova, O., Wang, J.-J., Diebold, R.
 J., and Schwartz, A. (<year>1991</year>) <source>Neuron</source>
 <volume>7</volume>
 <fpage>35</fpage>â44<pub-id pub-id-type="pmid">1648940</pub-id></mixed-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <mixed-citation publication-type="journal">Williams, M. E., Feldman, D. H., McCue, A. F., Brenner, R.,
 Velicelebi, G., Ellis, S. B., and Harpold, M. M. (<year>1992</year>)
 <source>Neuron</source> <volume>8</volume>
 <fpage>71</fpage>â84<pub-id pub-id-type="pmid">1309651</pub-id></mixed-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <mixed-citation publication-type="journal">Pichler, M., Cassidy, T. N., Reimer, D., Haase, H., Kraus, R.,
 Ostler, D., and Striessnig, J. (<year>1997</year>) <source>J. Biol.
 Chem.</source> <volume>272</volume>
 <fpage>13877</fpage>â13882<pub-id pub-id-type="pmid">9153247</pub-id></mixed-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <mixed-citation publication-type="journal">Mangoni, M. E., Couette, B., Bourinet, E., Platzer, J., Reimer, D.,
 Striessnig, J., and Nargeot, J. (<year>2003</year>) <source>Proc. Natl.
 Acad. Sci. U. S. A.</source> <volume>100</volume>
 <fpage>5543</fpage>â5548<pub-id pub-id-type="pmid">12700358</pub-id></mixed-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <mixed-citation publication-type="journal">Matthes, J., Yildirim, L., Wietzorrek, G., Reimer, D., Striessnig,
 J., and Herzig, S. (<year>2004</year>) <source>Naunyn-Schmiedeberg's Arch.
 Pharmacol.</source> <volume>369</volume>
 <fpage>554</fpage>â562<pub-id pub-id-type="pmid">15146309</pub-id></mixed-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <mixed-citation publication-type="journal">Bean, B. P. (<year>2007</year>) <source>Nature</source>
 <volume>447</volume>
 <fpage>1059</fpage>â1060<pub-id pub-id-type="pmid">17597746</pub-id></mixed-citation>
      </ref>
      <ref id="ref33">
        <label>33</label>
        <mixed-citation publication-type="journal">Safa, P., Boulter, J., and Hales, T. G. (<year>2001</year>)
 <source>J. Biol. Chem.</source> <volume>276</volume>
 <fpage>38727</fpage>â38737<pub-id pub-id-type="pmid">11514547</pub-id></mixed-citation>
      </ref>
      <ref id="ref34">
        <label>34</label>
        <mixed-citation publication-type="journal">Hell, J. W., Westenbroek, R. E., Breeze, L. J., Wang, K. K.,
 Chavkin, C., and Catterall, W. A. (<year>1996</year>) <source>Proc. Natl.
 Acad. Sci. U. S. A.</source> <volume>93</volume>
 <fpage>3362</fpage>â3367<pub-id pub-id-type="pmid">8622942</pub-id></mixed-citation>
      </ref>
      <ref id="ref35">
        <label>35</label>
        <mixed-citation publication-type="journal">Hulme, J. T., Westenbroek, R. E., Scheuer, T., and Catterall, W. A.
 (<year>2006</year>) <source>Proc. Natl. Acad. Sci. U. S. A.</source>
 <volume>103</volume>
 <fpage>16574</fpage>â16579<pub-id pub-id-type="pmid">17053072</pub-id></mixed-citation>
      </ref>
      <ref id="ref36">
        <label>36</label>
        <mixed-citation publication-type="journal">Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C.,
 Tkatch, T., Meredith, G. E., and Surmeier, D. J. (<year>2007</year>)
 <source>Nature</source> <volume>447</volume>
 <fpage>1081</fpage>â1086<pub-id pub-id-type="pmid">17558391</pub-id></mixed-citation>
      </ref>
      <ref id="ref37">
        <label>37</label>
        <mixed-citation publication-type="journal">Zhang, H., Fu, Y., Altier, C., Platzer, J., Surmeier, D. J., and
 Bezprozvanny, I. (<year>2006</year>) <source>Eur. J. Neurosci.</source>
 <volume>23</volume>
 <fpage>2297</fpage>â2310<pub-id pub-id-type="pmid">16706838</pub-id></mixed-citation>
      </ref>
      <ref id="ref38">
        <label>38</label>
        <mixed-citation publication-type="journal">Kepplinger, K. J., Kahr, H., Forstner, G., Sonnleitner, M.,
 Schindler, H., Schmidt, T., Groschner, K., Soldatov, N. M., and Romanin, C.
 (<year>2000</year>) <source>FEBS Lett.</source>
 <volume>477</volume>
 <fpage>161</fpage>â169<pub-id pub-id-type="pmid">10908714</pub-id></mixed-citation>
      </ref>
      <ref id="ref39">
        <label>39</label>
        <mixed-citation publication-type="journal">Calin-Jageman, I., Yu, K., Hall, R. A., Mei, L., and Lee, A.
 (<year>2007</year>) <source>J. Neurosci.</source>
 <volume>27</volume>
 <fpage>1374</fpage>â1385<pub-id pub-id-type="pmid">17287512</pub-id></mixed-citation>
      </ref>
      <ref id="ref40">
        <label>40</label>
        <mixed-citation publication-type="journal">Zhang, H., Maximov, A., Fu, Y., Xu, F., Tang, T. S., Tkatch, T.,
 Surmeier, D. J., and Bezprozvanny, I. (<year>2005</year>) <source>J.
 Neurosci.</source> <volume>25</volume>
 <fpage>1037</fpage>â1049<pub-id pub-id-type="pmid">15689539</pub-id></mixed-citation>
      </ref>
      <ref id="ref41">
        <label>41</label>
        <mixed-citation publication-type="journal">Hibino, H., Pironkova, R., Onwumere, O., Vologodskaia, M.,
 Hudspeth, A. J., and Lesage, F. (<year>2002</year>)
 <source>Neuron</source> <volume>34</volume>
 <fpage>411</fpage>â423<pub-id pub-id-type="pmid">11988172</pub-id></mixed-citation>
      </ref>
      <ref id="ref42">
        <label>42</label>
        <mixed-citation publication-type="journal">Qu, Y., Baroudi, G., Yue, Y., El-Sherif, N., and Boutjdir, M.
 (<year>2005</year>) <source>Am. J. Physiol.</source>
 <volume>288</volume>
 <fpage>H2123</fpage>âH2130</mixed-citation>
      </ref>
      <ref id="ref43">
        <label>43</label>
        <mixed-citation publication-type="journal">Hulme, J. T., Ahn, M., Hauschka, S. D., Scheuer, T., and Catterall,
 W. A. (<year>2002</year>) <source>J. Biol. Chem.</source>
 <volume>277</volume>
 <fpage>4079</fpage>â4087<pub-id pub-id-type="pmid">11733497</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn id="fn2">
        <label>2</label>
        <p>The abbreviations used are: LTCC, L-type Ca<sup>2+</sup> channel; ANOVA,
 analysis of variance; GFP, green fluorescent protein; YFP, yellow fluorescent
 protein; EYFP, enhanced YFP; CFP, cyan fluorescent protein; RT, reverse
 transcription; FRET, fluorescence resonance energy transfer; CTM, C-terminal
 gating modulator; CDI, calcium-dependent inactivation; DCRD, distal C-terminal
 regulatory domain; VDF, voltage-dependent facilitation; fwd, forward; rev,
 reverse; IHC, inner hair cells; GAPDH, glyceraldehyde-3-phosphate
 dehydrogenase; SAN, sinoatrial node; CaM, calmodulin; PCRD, primal C-terminal
 regulatory domain.</p>
      </fn>
    </fn-group>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>